
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Trajectory pattern of serially measured acute kidney injury biomarkers in critically ill patients: a prospective observational study - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="322C300B24F392050000617C3562DC63.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="aic" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC11156822/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11156822/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Annals of Intensive Care" /><meta name="citation_title" content="Trajectory pattern of serially measured acute kidney injury biomarkers in critically ill patients: a prospective observational study" /><meta name="citation_author" content="Ryohei Horie" /><meta name="citation_author_institution" content="Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655 Japan" /><meta name="citation_author" content="Naoki Hayase" /><meta name="citation_author_institution" content="Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655 Japan" /><meta name="citation_author" content="Toshifumi Asada" /><meta name="citation_author_institution" content="Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655 Japan" /><meta name="citation_author" content="Miyuki Yamamoto" /><meta name="citation_author_institution" content="Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655 Japan" /><meta name="citation_author" content="Takehiro Matsubara" /><meta name="citation_author_institution" content="Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655 Japan" /><meta name="citation_author" content="Kent Doi" /><meta name="citation_author_institution" content="Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655 Japan" /><meta name="citation_publication_date" content="2024" /><meta name="citation_volume" content="14" /><meta name="citation_doi" content="10.1186/s13613-024-01328-9" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC11156822/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC11156822/" /><meta name="citation_pmid" content="38842613" /><meta name="DC.Title" content="Trajectory pattern of serially measured acute kidney injury biomarkers in critically ill patients: a prospective observational study" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Springer" /><meta name="DC.Contributor" content="Ryohei Horie" /><meta name="DC.Contributor" content="Naoki Hayase" /><meta name="DC.Contributor" content="Toshifumi Asada" /><meta name="DC.Contributor" content="Miyuki Yamamoto" /><meta name="DC.Contributor" content="Takehiro Matsubara" /><meta name="DC.Contributor" content="Kent Doi" /><meta name="DC.Date" content="2024" /><meta name="DC.Identifier" content="10.1186/s13613-024-01328-9" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Trajectory pattern of serially measured acute kidney injury biomarkers in critically ill patients: a prospective observational study" /><meta property="og:type" content="article" /><meta property="og:description" content="The clinical value of the trajectory of temporal changes in acute kidney injury (AKI) biomarkers has not been well established among intensive care unit (ICU) patients.This is a single-center, prospective observational study, performed at a mixed ICU ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11156822/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11156822/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/1590/">Ann Intensive Care</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/452695/">v.14; 2024</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC11156822
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC11156822/pdf/13613_2024_Article_1328.pdf" class="int-view">PDF (887K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/11156822/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/11156822/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="11156822" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11156822%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="wpoUBZetjE5unujqfv9CcLfdfYORXfOuWrDekK20OmWKkBtq1AB4pC4o9F42OEh6">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11156822%2F&amp;text=Trajectory%20pattern%20of%20serially%20measured%20acute%20kidney%20injury%20biomarkers%20in%20critically%20ill%20patients%3A%20a%20prospective%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11156822%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11156822/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC11156822/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/38842613/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC11156822/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/38842613/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC11156822/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/11156822/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/1590/">Ann Intensive Care</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/452695/">v.14; 2024</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC11156822
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-aic.jpg" alt="Logo of aic" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://www.annalsofintensivecare.com" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Ann Intensive Care.</span> 2024; 14: 84. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2024 Jun 6. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1186%2Fs13613-024-01328-9" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/s13613-024-01328-9</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC11156822</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38842613">38842613</a></div></div></div><h1 class="content-title">Trajectory pattern of serially measured acute kidney injury biomarkers in critically ill patients: a prospective observational study</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Horie%20R%5BAuthor%5D" class="affpopup" co-rid="_co_idm140336135755952" co-class="co-affbox">Ryohei Horie</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup></sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hayase%20N%5BAuthor%5D" class="affpopup" co-rid="_co_idm140336141318688" co-class="co-affbox">Naoki Hayase</a>,<sup></sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Asada%20T%5BAuthor%5D" class="affpopup" co-rid="_co_idm140336142564496" co-class="co-affbox">Toshifumi Asada</a>,<sup></sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yamamoto%20M%5BAuthor%5D" class="affpopup" co-rid="_co_idm140336148210704" co-class="co-affbox">Miyuki Yamamoto</a>,<sup></sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Matsubara%20T%5BAuthor%5D" class="affpopup" co-rid="_co_idm140336127657504" co-class="co-affbox">Takehiro Matsubara</a>,<sup></sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Doi%20K%5BAuthor%5D" class="affpopup" co-rid="_co_idm140336127656096" co-class="co-affbox">Kent Doi</a><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140336135755952"><h3 class="no_margin">Ryohei Horie</h3><p>Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655 Japan </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Horie%20R%5BAuthor%5D">Ryohei Horie</a></div></div><div id="_co_idm140336141318688"><h3 class="no_margin">Naoki Hayase</h3><p>Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655 Japan </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hayase%20N%5BAuthor%5D">Naoki Hayase</a></div></div><div id="_co_idm140336142564496"><h3 class="no_margin">Toshifumi Asada</h3><p>Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655 Japan </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Asada%20T%5BAuthor%5D">Toshifumi Asada</a></div></div><div id="_co_idm140336148210704"><h3 class="no_margin">Miyuki Yamamoto</h3><p>Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655 Japan </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Yamamoto%20M%5BAuthor%5D">Miyuki Yamamoto</a></div></div><div id="_co_idm140336127657504"><h3 class="no_margin">Takehiro Matsubara</h3><p>Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655 Japan </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Matsubara%20T%5BAuthor%5D">Takehiro Matsubara</a></div></div><div id="_co_idm140336127656096"><h3 class="no_margin">Kent Doi</h3><p>Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655 Japan </p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Doi%20K%5BAuthor%5D">Kent Doi</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140336149158320_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140336149158320_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140336149158320_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140336149158320_ai" style="display:none"><div class="fm-affl" id="Aff1">Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655 Japan </div><div><span class="fm-affl">Ryohei Horie, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.ca.nimu@ykt-eirohr" class="oemail">pj.ca.nimu@ykt-eirohr</a></span>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes hide half_rhythm" id="idm140336149158320_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2023 Oct 12; Accepted 2024 Jun 2.</div></div><div class="permissions half_rhythm hide" id="idm140336149158320_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; The Author(s) 2024</div><div class="license half_rhythm"><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/4.0/</a>.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="3" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Material 1.</div><div><a href="/pmc/articles/PMC11156822/bin/13613_2024_1328_MOESM1_ESM.docx" data-ga-action="click_feat_suppl">13613_2024_1328_MOESM1_ESM.docx</a><span style="color:gray"> (393K)</span></div><div class="small guid">GUID: 5D4852B4-146C-466C-88CF-55986ACC0132</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Material 2.</div><div><a href="/pmc/articles/PMC11156822/bin/13613_2024_1328_MOESM2_ESM.docx" data-ga-action="click_feat_suppl">13613_2024_1328_MOESM2_ESM.docx</a><span style="color:gray"> (1.2M)</span></div><div class="small guid">GUID: D79F65F3-4AB9-4AFE-9BAE-CA6DE49AD3D2</div></div><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplementary Material 3.</div><div><a href="/pmc/articles/PMC11156822/bin/13613_2024_1328_MOESM3_ESM.xlsx" data-ga-action="click_feat_suppl">13613_2024_1328_MOESM3_ESM.xlsx</a><span style="color:gray"> (41K)</span></div><div class="small guid">GUID: 0ECD02B2-9191-4411-868B-57EF98FFDC5A</div></div></dd></dl><dl data-length="116" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p>The dataset supporting the conclusions of this article is included within the article (and its additional file (s)).</p></dd></dl></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="sec-a.l.b.n.a" class="sec sec-first"><h3 id="sec-a.l.b.n.atitle">Background</h3><p id="Par1" class="p p-first-last">The clinical value of the trajectory of temporal changes in acute kidney injury (AKI) biomarkers has not been well established among intensive care unit (ICU) patients.</p></div><div id="sec-a.l.b.n.b" class="sec"><h3 id="sec-a.l.b.n.btitle">Methods</h3><p id="Par2" class="p p-first-last">This is a single-center, prospective observational study, performed at a mixed ICU in a teaching medical institute in Tokyo, Japan. Adult ICU patients with an arterial line and urethral catheter were enrolled from September 2014 to March 2015. Patients who stayed in the ICU for less than 48&#x000a0;h and patients with known end-stage renal disease were excluded from the study. Blood and urine samples were collected for measurement of AKI biomarkers at 0, 12, 24, and 48&#x000a0;h after ICU admission. The primary outcome was major adverse kidney events (MAKE) at discharge, defined as a composite of death, dialysis dependency, and persistent loss of kidney function (&#x02265;&#x02009;25% decline in eGFR).</p></div><div id="sec-a.l.b.n.c" class="sec"><h3 id="sec-a.l.b.n.ctitle">Results</h3><p id="Par3" class="p p-first-last">The study included 156 patients. Serum creatinine-based estimated glomerular filtration rate (eGFR), plasma neutrophil gelatinase-associated lipocalin (NGAL), and urinary liver-type fatty acid-binding protein (uL-FABP) were serially measured and each variable was classified into three groups based on group-based trajectory modeling analysis. While the trajectory curves moved parallel to each other (i.e., &#x0201c;low,&#x0201d; &#x0201c;middle,&#x0201d; and &#x0201c;high&#x0201d;) for eGFR and plasma NGAL, the uL-FABP curves showed distinct trajectory patterns and moved in different directions (&#x0201c;low and constant,&#x0201d; &#x0201c;high and exponential decrease,&#x0201d; and &#x0201c;high and exponential increase&#x0201d;). These trajectory patterns were significantly associated with MAKE. MAKE occurred in 16 (18%), 16 (40%), and 9 (100%) patients in the &#x0201c;low and constant,&#x0201d; &#x0201c;high and exponential decrease,&#x0201d; and &#x0201c;high and exponential increase&#x0201d; groups, respectively, based on uL-FABP levels (p-value&#x02009;&#x0003c;&#x02009;0.001). The initial value and the 12-h change in uL-FABP were both significantly associated with MAKE, even after adjusting for eGFR [Odds ratio (95% confidence interval): 1.45 (1.17&#x02013;1.83) and 1.43 (1.12&#x02013;1.88) for increase of initial value and 12-h change of log-transformed uL-FABP by 1 point, respectively].</p></div><div id="sec-a.l.b.n.d" class="sec"><h3 id="sec-a.l.b.n.dtitle">Conclusions</h3><p id="Par4" class="p p-first-last">Trajectory pattern of serially measured urinary L-FABP was significantly associated with MAKE in ICU patients.</p></div><div id="sec-a.l.b.n.e" class="sec sec-last"><h3 id="sec-a.l.b.n.etitle">Supplementary Information</h3><p class="p p-first-last">The online version contains supplementary material available at 10.1186/s13613-024-01328-9.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Acute kidney injury, Biomarker, Trajectory, Neutrophil gelatinase-associated lipocalin, Liver-type fatty acid-binding protein, Major adverse kidney event, Group-based trajectory modeling</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Background</h2><p id="Par26" class="p p-first">Acute kidney injury (AKI) is a common problem in various clinical settings, including intensive care units (ICUs) [<a href="#CR1" rid="CR1" class=" bibr popnode">1</a>&#x02013;<a href="#CR5" rid="CR5" class=" bibr popnode">5</a>]. AKI is associated with poor clinical outcomes, including increased mortality, renal replacement therapy (RRT) dependence, and progression to chronic kidney disease (CKD) [<a href="#CR2" rid="CR2" class=" bibr popnode">2</a>, <a href="#CR3" rid="CR3" class=" bibr popnode">3</a>, <a href="#CR5" rid="CR5" class=" bibr popnode">5</a>&#x02013;<a href="#CR8" rid="CR8" class=" bibr popnode">8</a>]. Although substantial efforts have been made to accurately diagnose AKI early and improve outcomes [<a href="#CR4" rid="CR4" class=" bibr popnode">4</a>, <a href="#CR9" rid="CR9" class=" bibr popnode">9</a>], challenges in these areas still exist. The current standard diagnostic criteria for AKI are based on the Kidney Disease: Improving Global Outcomes (KDIGO) criteria; AKI is diagnosed based on serum creatinine (sCr) and urine output (UOP) levels [<a href="#CR10" rid="CR10" class=" bibr popnode">10</a>]. However, sCr and UOP are indices of kidney function, rather than kidney damage, and may not directly reflect the pathology of AKI [<a href="#CR9" rid="CR9" class=" bibr popnode">9</a>].</p><p id="Par27">To address limitations in diagnosing AKI, various biomarkers for direct assessment of renal injury have been proposed [<a href="#CR11" rid="CR11" class=" bibr popnode">11</a>, <a href="#CR12" rid="CR12" class=" bibr popnode">12</a>]. Neutrophil gelatinase-associated lipocalin (NGAL) and liver-type fatty acid-binding protein (L-FABP) are direct biomarkers of kidney damage. NGAL and L-FABP originate mainly in the distal and proximal tubules, respectively, and detect early-stage AKI [<a href="#CR9" rid="CR9" class=" bibr popnode">9</a>]. For example, elevated urine or plasma NGAL levels are associated with higher mortality rates among critically ill patients, even without sCr elevation [<a href="#CR13" rid="CR13" class=" bibr popnode">13</a>]. Perioperative urine L-FABP (uL-FABP) predicts AKI development before sCr elevation among patients undergoing abdominal aneurysm repairs [<a href="#CR14" rid="CR14" class=" bibr popnode">14</a>]. In addition to early detection of AKI, clinical studies reported promising results for these novel biomarkers in the prognosis of critically ill patients [<a href="#CR13" rid="CR13" class=" bibr popnode">13</a>, <a href="#CR15" rid="CR15" class=" bibr popnode">15</a>&#x02013;<a href="#CR24" rid="CR24" class=" bibr popnode">24</a>]. Recently, a new framework of AKI classification has been proposed, in which both functional and damage biomarkers are combined [<a href="#CR25" rid="CR25" class=" bibr popnode">25</a>].</p><p id="Par28" class="p p-last">The associations of most AKI biomarkers with clinical outcomes were examined at single time points. Only a few studies reported the impact of serial measurements [<a href="#CR26" rid="CR26" class=" bibr popnode">26</a>&#x02013;<a href="#CR29" rid="CR29" class=" bibr popnode">29</a>], and the patterns of chronological changes were not assessed. In this study, the trajectory patterns of plasma NGAL and uL-FABP were investigated using group-based trajectory modeling [<a href="#CR30" rid="CR30" class=" bibr popnode">30</a>&#x02013;<a href="#CR32" rid="CR32" class=" bibr popnode">32</a>]. The objective of this study was to evaluate the association of the trajectory patterns of AKI biomarkers with major adverse kidney events (MAKE), defined as the composite outcome of death, new dialysis, and worsening renal function [<a href="#CR33" rid="CR33" class=" bibr popnode">33</a>].</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Methods</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Study design</h3><p id="Par29" class="p p-first-last">The aim of this study was to evaluate the association of the trajectory patterns of AKI biomarkers with MAKE among critically ill patients. A single-center, prospective observational study was performed in a mixed ICU at the University of Tokyo Hospital, Tokyo, Japan. The study protocol was approved by the Research Ethics Committee of the Faculty of Medicine of the University of Tokyo (Approval No. 2810-13; title: &#x0201c;Establishment of blood and urinary biomarker for acute kidney injury&#x0201d; on December 7, 2009). Written informed consent was obtained from the patient or surrogate decision maker. All procedures were followed in accordance with the ethical standards of the Research Ethics Committee of the Faculty of Medicine of the University of Tokyo and with the Helsinki Declaration of 1975.</p></div><div id="Sec4" class="sec"><h3 id="Sec4title">Patients</h3><p id="Par30" class="p p-first-last">Adult patients admitted to the ICU from September 2014 to March 2015 were screened for enrollment. The inclusion criteria were: (1) patients with an arterial line and urethral catheter for monitoring blood pressure and urine output so serial blood and urine tests could be performed with the existing catheters and (2) written informed consent was signed by the patient or the surrogate decision maker. Patients meeting the following criteria were excluded: (1) patients who were discharged from the ICU within 48&#x000a0;h of ICU admission and (2) patients who had a known diagnosis of end-stage renal disease (ESRD) before admission.</p></div><div id="Sec5" class="sec"><h3 id="Sec5title">Measurements</h3><p id="Par31" class="p p-first-last">Upon ICU admission, patient demographics were obtained from the electronic medical records. The patients underwent serial blood and urine tests, including sCr for estimated glomerular filtration rate (eGFR), plasma NGAL, and uL-FABP, at 0, 12, 24, and 48&#x000a0;h after ICU admission. Serum creatinine levels were measured at the central laboratory of our hospital using the enzymatic method with LABOSPECT 008 &#x003b1; (Hitachi High-Tech&#x000ae;, reference ranges: 0.65&#x02013;1.07&#x000a0;mg/dL for males and 0.46&#x02013;0.79&#x000a0;mg/dL for females). The eGFRs were calculated based on the Modified Diet Renal Disease (MDRD) equation for Japanese patients [<a href="#CR34" rid="CR34" class=" bibr popnode">34</a>]. Plasma NGAL was determined using the Triage&#x000ae; NGAL Device (Alere Medical, Inc., San Diego, CA, USA). Urinary L-FABP was measured using an enzyme-linked immunosorbent assay (Human L-FABP Assay Kit; CMIC, Tokyo, Japan). The uL-FABP values were normalized against urinary creatinine levels prior to analysis.</p></div><div id="Sec6" class="sec"><h3 id="Sec6title">Outcomes</h3><p id="Par32" class="p p-first-last">The primary outcome was MAKE at hospital discharge, defined as a composite of death, dialysis dependency, and persistent loss of kidney function (&#x02265;&#x02009;25% decline in eGFR) [<a href="#CR33" rid="CR33" class=" bibr popnode">33</a>]. The secondary outcomes included hospital death, the presence and the stage of AKI on day 7 after ICU admission, and RRT requirement during hospitalization. Sex, age, surgical intervention, acute physiology and chronic health evaluation (APACHE) II score, presence of CKD, sepsis, shock, and urinary tract infection were treated as potential confounders. The diagnosis of AKI was defined as a sCr increase from baseline of more than 0.3&#x000a0;mg/dL or 50% within 48&#x000a0;h or 7&#x000a0;days, respectively, based on the KDIGO guideline [<a href="#CR10" rid="CR10" class=" bibr popnode">10</a>]. The baseline sCr and eGFR were defined as the last outpatient measurements within 6&#x000a0;months before ICU admission. For patients without an outpatient measurement, the baseline sCr was defined as the lowest value of admission sCr, discharge sCr, or sCr corresponding with an eGFR of 75&#x000a0;mL/min/1.73 m<sup>2</sup> using the MDRD equation.</p></div><div id="Sec7" class="sec sec-last"><h3 id="Sec7title">Statistical analysis</h3><p id="Par33" class="p p-first">R ver 4.1.0 was used for statistical analyses and p-values&#x02009;&#x0003c;&#x02009;0.05 were considered significant. Plasma NGAL and uL-FABP were log-transformed prior to the analysis, due to their marked skewness in distribution.</p><p id="Par34">The trajectory patterns were analyzed by performing group-based trajectory modeling for eGFR, log (NGAL), and log (uL-FABP). Group-based trajectory modeling is a statistical method which allows to categorize a group of patients into subclasses based on the trajectory patterns of a continuous variable changing over time (More details can be found in supplemental document). The trajectory patterns were modeled to follow the quadratic function of time in hours after ICU admission. Patients who had more than two missing measurements (out of all four measurements) in the variable of interest were excluded from the model. An extreme outlier was also excluded when it was necessary to generate meaningful trajectory models. Group-based trajectory modeling was performed using the lcmm package (ver 1.9.4), by assuming no random effects [<a href="#CR31" rid="CR31" class=" bibr popnode">31</a>, <a href="#CR32" rid="CR32" class=" bibr popnode">32</a>]. The appropriate number of trajectory classes was selected based on the combination of the Bayesian information criterion, the number of patients in each class (at least 3% of the patients in the smallest class was considered the minimal requirement), and the model interpretability. The model performances were assessed using the average of the posterior probability assignment and the relative entropy. In this study, the models of three trajectory classes and those with four trajectory classes seemed appropriate. From the model interpretability stand point, 3-class models were selected and analyzed. Further statistical details of the trajectory analysis were summarized in supplemental document. The classes in the selected model and the outcomes were compared using Fisher&#x02019;s exact tests.</p><p id="Par35" class="p p-last">A conventional statistical approach using a multivariate logistic regression model was also conducted. Multivariate logistic regression models to predict MAKE with different sets of predictor variables were created. The initial value (time0) and the changes between time 0 and 12&#x000a0;h of ICU stay (delta12) were used for eGFR, log (NGAL), and log (uL-FABP). For model comparison, the continuous net reclassification improvement (cNRI) and the integrated discrimination improvement (IDI) were calculated using the PredictABEL package (ver 1.2.4). After the best model was selected based on the cNRI and IDI [the model included time0 and delta12 for eGFR and log (uL-FABP)], the integrated uL-FABP index (FABPi) was defined as the fitted value by the model. The cutoff of FABPi was determined using the Youden index. Patients were divided into &#x0201c;positive&#x0201d; and &#x0201c;negative&#x0201d; groups based on the FABPi cutoff. MAKE were compared in patients with &#x0201c;positive&#x0201d; and &#x0201c;negative&#x0201d; FABPi after balancing the potential confounders (sex, age, surgical patients, acute physiology and chronic health evaluation [APACHE] II score, presence of CKD, sepsis, shock, and urinary tract infection) using inverse probability weighting (IPW). For evaluation of the clinical impact, the odds ratios with 95% confidence intervals were calculated based on the cluster-robust standard error using the lmtest (ver 0.9.40) and sandwich (ver 3.0.2) R packages. Patients with missing variables were excluded from the models requiring those specific missing variables.</p></div></div><div id="Sec8" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec8title">Results</h2><div id="Sec9" class="sec sec-first"><h3 id="Sec9title">Patient characteristics</h3><p id="Par36" class="p p-first-last">During the study period, 197 patients were screened, of which 156 patients were enrolled. The study enrollment process and the number of excluded patients from each statistical model was shown in Fig.&#x000a0;<a href="/pmc/articles/PMC11156822/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1</span></a>. The basic patient characteristics are shown in Table&#x000a0;<a href="/pmc/articles/PMC11156822/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span>1</span></a>. The median age of the enrolled patients was 65-year-old with interquartile range (IQR) of 55- to 75-year-old, and 96 patients (62%) were male. MAKE occurred in 44 patients (28%). Stage 3 AKI was more common among those with MAKE. Patients with MAKE tended to be more severely ill than patients without MAKE, based on APACHE II and sequential organ failure assessment (SOFA) scores. The rates of sepsis, shock, UTI, surgery, and CKD did not show statistically significant differences between those with and without MAKE. As expected, patients with MAKE tended to have higher sCr, lower eGFR, higher plasma NGAL, and higher uL-FABP at ICU admission (Table&#x000a0;<a href="/pmc/articles/PMC11156822/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span>1</span></a> and Fig.&#x000a0;<a href="/pmc/articles/PMC11156822/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2</span></a>). Marked skewness was observed in the distributions of plasma NGAL and uL-FABP; therefore, these parameters were log-transformed for further statistical analyses (Supplemental Fig. 1).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC11156822/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140336143022816"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11156822_13613_2024_1328_Fig1_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13613_2024_1328_Fig1_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11156822/bin/13613_2024_1328_Fig1_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140336143022816"><a target="object" rel="noopener" href="/pmc/articles/PMC11156822/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC11156822/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Fig.&#x000a0;1</a></div><!--caption a7--><div class="caption"><p>Study design and statistical model development. After patient enrollment, two types of analyses were performed, i.e., analysis of the trajectory patterns and multivariate logistic regression model. One patient (outlier) was excluded from the analysis of the trajectory patterns for eGFR, due to extremely high values (295.6, 347.0, 391.9, and 328.1&#x000a0;mL/min/1.73 m<sup>2</sup> at time 0, 12, 24, and 48&#x000a0;h after ICU admission, respectively). <em>ESRD</em> end-stage renal disease, <em>eGFR</em> estimated glomerular filtration rate, <em>uL-FABP</em> urinary liver-type fatty acid-binding protein, <em>ICU</em> intensive care unit, <em>NGAL</em> neutrophil gelatinase-associated lipocalin</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab1"><h3>Table&#x000a0;1</h3><!--caption a7--><div class="caption"><p>Patient characteristics</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="left" rowspan="1" colspan="1">Overall<br />N&#x02009;=&#x02009;156</th><th align="left" rowspan="1" colspan="1">MAKE (&#x02009;+)<br />n&#x02009;=&#x02009;44</th><th align="left" rowspan="1" colspan="1">MAKE (&#x02212;)<br />n&#x02009;=&#x02009;112</th><th align="left" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, y</td><td align="center" rowspan="1" colspan="1">65 (55, 75)</td><td align="center" rowspan="1" colspan="1">68 (57, 79)</td><td align="center" rowspan="1" colspan="1">64 (53, 73)</td><td align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex, male</td><td align="center" rowspan="1" colspan="1">96 (62)</td><td align="center" rowspan="1" colspan="1">26 (59)</td><td align="center" rowspan="1" colspan="1">70 (62)</td><td align="center" rowspan="1" colspan="1">0.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Death</td><td align="center" rowspan="1" colspan="1">22 (14)</td><td align="center" rowspan="1" colspan="1">22 (50)</td><td align="center" rowspan="1" colspan="1">0 (0)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">ICU length of stay</td><td align="center" rowspan="1" colspan="1">5 (3, 9)</td><td align="center" rowspan="1" colspan="1">7 (3, 12)</td><td align="center" rowspan="1" colspan="1">5 (3, 8)</td><td align="center" rowspan="1" colspan="1">0.065</td></tr><tr><td align="left" rowspan="1" colspan="1">Hospital length of stay</td><td align="center" rowspan="1" colspan="1">44 (17, 80)</td><td align="center" rowspan="1" colspan="1">44 (13, 84)</td><td align="center" rowspan="1" colspan="1">44 (19, 78)</td><td align="center" rowspan="1" colspan="1">0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">Day1 AKI</td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;No AKI</td><td align="center" rowspan="1" colspan="1">85 (54)</td><td align="center" rowspan="1" colspan="1">16 (36)</td><td align="center" rowspan="1" colspan="1">69 (62)</td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 1</td><td align="center" rowspan="1" colspan="1">31 (20)</td><td align="center" rowspan="1" colspan="1">9 (20)</td><td align="center" rowspan="1" colspan="1">22 (20)</td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 2</td><td align="center" rowspan="1" colspan="1">18 (12)</td><td align="center" rowspan="1" colspan="1">5 (11)</td><td align="center" rowspan="1" colspan="1">13 (12)</td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 3</td><td align="center" rowspan="1" colspan="1">22 (14)</td><td align="center" rowspan="1" colspan="1">14 (32)</td><td align="center" rowspan="1" colspan="1">8 (7.1)</td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Day7 AKI</td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;No AKI</td><td align="center" rowspan="1" colspan="1">111 (74)</td><td align="center" rowspan="1" colspan="1">15 (38)</td><td align="center" rowspan="1" colspan="1">96 (86)</td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 1</td><td align="center" rowspan="1" colspan="1">20 (13)</td><td align="center" rowspan="1" colspan="1">9 (23)</td><td align="center" rowspan="1" colspan="1">11 (9.8)</td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 2</td><td align="center" rowspan="1" colspan="1">8 (5.3)</td><td align="center" rowspan="1" colspan="1">6 (15)</td><td align="center" rowspan="1" colspan="1">2 (1.8)</td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 3</td><td align="center" rowspan="1" colspan="1">12 (7.9)</td><td align="center" rowspan="1" colspan="1">9 (23)</td><td align="center" rowspan="1" colspan="1">3 (2.7)</td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">RRT need</td><td align="center" rowspan="1" colspan="1">17 (11)</td><td align="center" rowspan="1" colspan="1">13 (30)</td><td align="center" rowspan="1" colspan="1">4 (3.6)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Sepsis</td><td align="center" rowspan="1" colspan="1">20 (13)</td><td align="center" rowspan="1" colspan="1">7 (16)</td><td align="center" rowspan="1" colspan="1">13 (12)</td><td align="center" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Shock</td><td align="center" rowspan="1" colspan="1">24 (15)</td><td align="center" rowspan="1" colspan="1">8 (18)</td><td align="center" rowspan="1" colspan="1">16 (14)</td><td align="center" rowspan="1" colspan="1">0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">UTI</td><td align="center" rowspan="1" colspan="1">6 (3.8)</td><td align="center" rowspan="1" colspan="1">3 (6.8)</td><td align="center" rowspan="1" colspan="1">3 (2.7)</td><td align="center" rowspan="1" colspan="1">0.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Surgery</td><td align="center" rowspan="1" colspan="1">66 (42)</td><td align="center" rowspan="1" colspan="1">17 (39)</td><td align="center" rowspan="1" colspan="1">49 (44)</td><td align="center" rowspan="1" colspan="1">0.6</td></tr><tr><td align="left" rowspan="1" colspan="1">CKD</td><td align="center" rowspan="1" colspan="1">33 (21)</td><td align="center" rowspan="1" colspan="1">10 (23)</td><td align="center" rowspan="1" colspan="1">23 (21)</td><td align="center" rowspan="1" colspan="1">0.8</td></tr><tr><td align="left" rowspan="1" colspan="1">APACHE II score</td><td align="center" rowspan="1" colspan="1">16 (12, 22)</td><td align="center" rowspan="1" colspan="1">20 (14, 25)</td><td align="center" rowspan="1" colspan="1">15 (12, 21)</td><td align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">SOFA score (day1)</td><td align="center" rowspan="1" colspan="1">6 (4, 9)</td><td align="center" rowspan="1" colspan="1">8 (6, 10)</td><td align="center" rowspan="1" colspan="1">5 (3, 8)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">sCr, mg/dL</td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;0&#x000a0;h</td><td align="center" rowspan="1" colspan="1">0.92 (0.63, 1.37)</td><td align="center" rowspan="1" colspan="1">1.22 (0.77, 2.09)</td><td align="center" rowspan="1" colspan="1">0.86 (0.62, 1.20)</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;12&#x000a0;h</td><td align="center" rowspan="1" colspan="1">0.86 (0.63, 1.30)</td><td align="center" rowspan="1" colspan="1">1.21 (0.82, 2.00)</td><td align="center" rowspan="1" colspan="1">0.78 (0.62, 1.08)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;24&#x000a0;h</td><td align="center" rowspan="1" colspan="1">0.85 (0.62, 1.40)</td><td align="center" rowspan="1" colspan="1">1.32 (0.85, 1.85)</td><td align="center" rowspan="1" colspan="1">0.77 (0.60, 1.14)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;48&#x000a0;h</td><td align="center" rowspan="1" colspan="1">0.78 (0.57, 1.26)</td><td align="center" rowspan="1" colspan="1">1.27 (0.77, 1.63)</td><td align="center" rowspan="1" colspan="1">0.70 (0.55, 0.96)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">eGFR, mL/min/1.73m<sup>2</sup></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;0&#x000a0;h</td><td align="center" rowspan="1" colspan="1">58 (39, 86)</td><td align="center" rowspan="1" colspan="1">41 (22, 73)</td><td align="center" rowspan="1" colspan="1">65 (46, 91)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;12&#x000a0;h</td><td align="center" rowspan="1" colspan="1">60 (40, 89)</td><td align="center" rowspan="1" colspan="1">38 (26, 56)</td><td align="center" rowspan="1" colspan="1">72 (51, 93)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;24&#x000a0;h</td><td align="center" rowspan="1" colspan="1">60 (39, 92)</td><td align="center" rowspan="1" colspan="1">40 (30, 52)</td><td align="center" rowspan="1" colspan="1">75 (47, 98)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;48&#x000a0;h</td><td align="center" rowspan="1" colspan="1">68 (41, 102)</td><td align="center" rowspan="1" colspan="1">41 (29, 60)</td><td align="center" rowspan="1" colspan="1">81 (56, 111)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">NGAL, ng/mL</td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;0&#x000a0;h</td><td align="center" rowspan="1" colspan="1">112 (58, 320)</td><td align="center" rowspan="1" colspan="1">168 (77, 409)</td><td align="center" rowspan="1" colspan="1">108 (54, 281)</td><td align="center" rowspan="1" colspan="1">0.029</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;12&#x000a0;h</td><td align="center" rowspan="1" colspan="1">142 (66, 316)</td><td align="center" rowspan="1" colspan="1">216 (98, 421)</td><td align="center" rowspan="1" colspan="1">104 (52, 252)</td><td align="center" rowspan="1" colspan="1">0.007</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;24&#x000a0;h</td><td align="center" rowspan="1" colspan="1">137 (78, 357)</td><td align="center" rowspan="1" colspan="1">195 (106, 626)</td><td align="center" rowspan="1" colspan="1">128 (70, 253)</td><td align="center" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;48&#x000a0;h</td><td align="center" rowspan="1" colspan="1">139 (85, 363)</td><td align="center" rowspan="1" colspan="1">246 (111, 540)</td><td align="center" rowspan="1" colspan="1">112 (83, 253)</td><td align="center" rowspan="1" colspan="1">0.010</td></tr><tr><td align="left" rowspan="1" colspan="1">uL-FABP, &#x003bc;g/gCr</td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;0&#x000a0;h</td><td align="center" rowspan="1" colspan="1">48 (14, 216)</td><td align="center" rowspan="1" colspan="1">130 (42, 1,038)</td><td align="center" rowspan="1" colspan="1">38 (12, 118)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;12&#x000a0;h</td><td align="center" rowspan="1" colspan="1">28 (14, 124)</td><td align="center" rowspan="1" colspan="1">88 (21, 1,090)</td><td align="center" rowspan="1" colspan="1">25 (13, 52)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;24&#x000a0;h</td><td align="center" rowspan="1" colspan="1">28 (12, 100)</td><td align="center" rowspan="1" colspan="1">72 (23, 394)</td><td align="center" rowspan="1" colspan="1">21 (11, 55)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;48&#x000a0;h</td><td align="center" rowspan="1" colspan="1">35 (10, 85)</td><td align="center" rowspan="1" colspan="1">68 (14, 278)</td><td align="center" rowspan="1" colspan="1">25 (9, 56)</td><td align="center" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140336143020240"><a target="object" rel="noopener" href="/pmc/articles/PMC11156822/table/Tab1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p><em>MAKE</em> major adverse kidney events at hospital discharge, <em>ICU</em> intensive care unit, <em>AKI</em> acute kidney injury, <em>RRT</em> renal replacement therapy, <em>UTI</em> urinary tract infection, <em>CKD</em> chronic kidney disease, <em>APACHE II score</em> acute physiology and chronic health evaluation II score, <em>SOFA score</em> sequential organ failure assessment score, <em>sCr</em> serum creatinine, <em>eGFR</em> estimated glomerular filtration rate, <em>NGAL</em> neutrophil gelatinase-associated lipocalin, <em>uL-FABP</em> urinary liver-type fatty acid-binding protein. Continuous variables are shown in median (interquartile range) and categorical variables are shown in count (percentage). Wilcoxon rank sum test, Pearson&#x02019;s Chi-squared test, and Fisher&#x02019;s exact test were used as appropriate to compare MAKE (&#x02009;+) group and MAKE (&#x02212;) group</p></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC11156822/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140336132809248"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11156822_13613_2024_1328_Fig2_HTML.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13613_2024_1328_Fig2_HTML.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC11156822/bin/13613_2024_1328_Fig2_HTML.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140336132809248"><a target="object" rel="noopener" href="/pmc/articles/PMC11156822/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC11156822/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Fig.&#x000a0;2</a></div><!--caption a7--><div class="caption"><p>Renal function and AKI biomarkers at different time points. Patients who developed MAKE tended to have higher sCr, lower eGFR, higher plasma NGAL, and higher uL-FABP, as compared to those without MAKE. <em>eGFR</em> estimated glomerular filtration rate, <em>uL-FABP</em> urinary liver-type fatty acid-binding protein, <em>MAKE</em> major adverse kidney events at discharge, <em>NGAL</em> neutrophil gelatinase-associated lipocalin, <em>sCr</em> serum creatinine</p></div></div></div></div><div id="Sec10" class="sec"><h3 id="Sec10title">Trajectory patterns</h3><p id="Par37" class="p p-first-last">As shown in Fig.&#x000a0;<a href="/pmc/articles/PMC11156822/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3</span></a>, the trajectory models for eGFR and log (NGAL) showed almost parallel classes, with differences in magnitude only. In contrast, the model for log (uL-FABP) exhibited differences in both the magnitude and direction of changes. These classes were named &#x0201c;low and constant,&#x0201d; &#x0201c;high and exponential decrease,&#x0201d; and &#x0201c;high and exponential increase.&#x0201d; Table&#x000a0;<a href="/pmc/articles/PMC11156822/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span>2</span></a> summarizes the relationship between the classes for each variable and clinical outcome. In the eGFR and log (NGAL) models, patients in the higher severity classes for the variable of interest tended to show worse clinical outcomes. On the other hand, in the log (uL-FABP) model, patients in the &#x0201c;high and exponential increase&#x0201d; class had the worst clinical outcomes, followed by the &#x0201c;high and exponential decrease&#x0201d; and &#x0201c;low and constant&#x0201d; classes. Specifically, MAKE occurred in 18% (16/89), 40% (16/40), and 100% (9/9) of patients in the &#x0201c;low and constant,&#x0201d; &#x0201c;high and exponential decrease,&#x0201d; and &#x0201c;high and exponential increase&#x0201d; classes of the uL-FABP trajectory groups, respectively (p&#x02009;&#x0003c;&#x02009;0.001). The temporal profile of AKI severity by uL-FABP trajectory classes is shown in supplemental Fig.&#x000a0;2. The patients in the &#x0201c;low and constant&#x0201d; group tended to have low AKI severity with minimal progression. The &#x0201c;high and exponential decrease&#x0201d; class included the patients with various levels of AKI severity and seemed to show the most remarkable tendency of recovery. AKI severity of the &#x0201c;high and exponential increase&#x0201d; class was the highest, with almost no recovery. Supplemental Fig. 3 is comparison of trajectory classes between different biomarkers. As expected, there appear to be associations in the trajectory patterns among these biomarkers. However, notably, many individuals in the &#x0201c;low&#x0201d; eGFR class were still in the &#x0201c;low and constant&#x0201d; uL-FABP class simultaneously.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC11156822/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140336137075968"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 13613_2024_1328_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 13613_2024_1328_Fig3_HTML.jpg" src="/pmc/articles/PMC11156822/bin/13613_2024_1328_Fig3_HTML.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140336137075968"><a target="object" rel="noopener" href="/pmc/articles/PMC11156822/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC11156822/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Fig.&#x000a0;3</a></div><!--caption a7--><div class="caption"><p>Trajectory patterns of kidney-related variables. Solid lines indicate the mean predicted trajectories. Dashed lines indicate the 95% confidence intervals. Note that NGAL and uL-FABP were log-transformed prior to the trajectory analysis. The trajectory models for eGFR and log (NGAL) showed almost parallel classes, with differences in magnitude only. In contrast, the model for log (uL-FABP) exhibited differences in both the magnitude and direction of changes. The class names of log (uL-FABP) are as follows. &#x0201c;High and exponential increase (H/eI),&#x0201d; &#x0201c;high and exponential decrease (H/eD),&#x0201d; and &#x0201c;low and constant (L/C).&#x0201d; <em>eGFR</em> estimated glomerular filtration rate, <em>uL-FABP</em> urinary liver-type fatty acid-binding protein, <em>NGAL</em> neutrophil gelatinase-associated lipocalin</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab2"><h3>Table&#x000a0;2</h3><!--caption a7--><div class="caption"><p>Trajectory patterns and clinical outcomes</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" colspan="5" rowspan="1">eGFR, N&#x02009;=&#x02009;144</th></tr><tr><th align="left" rowspan="1" colspan="1">Outcome</th><th align="left" rowspan="1" colspan="1">Low, n&#x02009;=&#x02009;72</th><th align="left" rowspan="1" colspan="1">Middle, n&#x02009;=&#x02009;42</th><th align="left" rowspan="1" colspan="1">High, n&#x02009;=&#x02009;30</th><th align="left" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">MAKE</td><td align="left" rowspan="1" colspan="1">34 (47)</td><td align="left" rowspan="1" colspan="1">4 (10)</td><td align="left" rowspan="1" colspan="1">5 (17)</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Day 7 AKI Stage<sup>a</sup></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;No AKI</td><td align="left" rowspan="1" colspan="1">33 (46)</td><td align="left" rowspan="1" colspan="1">38 (90)</td><td align="left" rowspan="1" colspan="1">28 (93)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 1</td><td align="left" rowspan="1" colspan="1">16 (22)</td><td align="left" rowspan="1" colspan="1">2 (5)</td><td align="left" rowspan="1" colspan="1">2 (7)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 2</td><td align="left" rowspan="1" colspan="1">7 (10)</td><td align="left" rowspan="1" colspan="1">1 (2)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 3</td><td align="left" rowspan="1" colspan="1">11 (15)</td><td align="left" rowspan="1" colspan="1">1 (2)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Day 1&#x02013;7 AKI Stage change<sup>a</sup></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Improved</td><td align="left" rowspan="1" colspan="1">25 (35)</td><td align="left" rowspan="1" colspan="1">9 (21)</td><td align="left" rowspan="1" colspan="1">5 (17)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Unchanged</td><td align="left" rowspan="1" colspan="1">27 (38)</td><td align="left" rowspan="1" colspan="1">32 (76)</td><td align="left" rowspan="1" colspan="1">24 (80)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Deteriorated</td><td align="left" rowspan="1" colspan="1">15 (21)</td><td align="left" rowspan="1" colspan="1">1 (2)</td><td align="left" rowspan="1" colspan="1">1 (3)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Death</td><td align="left" rowspan="1" colspan="1">18 (25)</td><td align="left" rowspan="1" colspan="1">1 (2)</td><td align="left" rowspan="1" colspan="1">3 (10)</td><td align="left" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">RRT</td><td align="left" rowspan="1" colspan="1">16 (22)</td><td align="left" rowspan="1" colspan="1">1 (2)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140336138431792"><a target="object" rel="noopener" href="/pmc/articles/PMC11156822/table/Tab2/?report=objectonly">Open in a separate window</a></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" colspan="5" rowspan="1">Log (NGAL), N&#x02009;=&#x02009;142</th></tr><tr><th align="left" rowspan="1" colspan="1">Outcome</th><th align="left" rowspan="1" colspan="1">Low, n&#x02009;=&#x02009;55</th><th align="left" rowspan="1" colspan="1">Middle, n&#x02009;=&#x02009;50</th><th align="left" rowspan="1" colspan="1">High, n&#x02009;=&#x02009;37</th><th align="left" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">MAKE</td><td align="left" rowspan="1" colspan="1">10 (18)</td><td align="left" rowspan="1" colspan="1">15 (30)</td><td align="left" rowspan="1" colspan="1">18 (49)</td><td align="left" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">Day 7 AKI Stage<sup>a</sup></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;No AKI</td><td align="left" rowspan="1" colspan="1">48 (87)</td><td align="left" rowspan="1" colspan="1">35 (70)</td><td align="left" rowspan="1" colspan="1">17 (46)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 1</td><td align="left" rowspan="1" colspan="1">5 (9)</td><td align="left" rowspan="1" colspan="1">9 (18)</td><td align="left" rowspan="1" colspan="1">5 (14)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 2</td><td align="left" rowspan="1" colspan="1">1 (2)</td><td align="left" rowspan="1" colspan="1">3 (6)</td><td align="left" rowspan="1" colspan="1">3 (8)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 3</td><td align="left" rowspan="1" colspan="1">1 (2)</td><td align="left" rowspan="1" colspan="1">0 (0)</td><td align="left" rowspan="1" colspan="1">10 (27)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Day 1&#x02013;7 AKI Stage change<sup>a</sup></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Improved</td><td align="left" rowspan="1" colspan="1">11 (20)</td><td align="left" rowspan="1" colspan="1">14 (28)</td><td align="left" rowspan="1" colspan="1">14 (38)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Unchanged</td><td align="left" rowspan="1" colspan="1">41 (75)</td><td align="left" rowspan="1" colspan="1">28 (56)</td><td align="left" rowspan="1" colspan="1">13 (35)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Deteriorated</td><td align="left" rowspan="1" colspan="1">3 (5)</td><td align="left" rowspan="1" colspan="1">5 (10)</td><td align="left" rowspan="1" colspan="1">8 (22)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Death</td><td align="left" rowspan="1" colspan="1">4 (7)</td><td align="left" rowspan="1" colspan="1">7 (14)</td><td align="left" rowspan="1" colspan="1">10 (27)</td><td align="left" rowspan="1" colspan="1">0.039</td></tr><tr><td align="left" rowspan="1" colspan="1">RRT</td><td align="left" rowspan="1" colspan="1">1 (2)</td><td align="left" rowspan="1" colspan="1">4 (8)</td><td align="left" rowspan="1" colspan="1">10 (27)</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140336137974576"><a target="object" rel="noopener" href="/pmc/articles/PMC11156822/table/Tab2/?report=objectonly">Open in a separate window</a></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" colspan="5" rowspan="1">Log (uL-FABP), N&#x02009;=&#x02009;138</th></tr><tr><th align="left" rowspan="1" colspan="1">Outcome</th><th align="left" rowspan="1" colspan="1">Low &#x00026; constant, n&#x02009;=&#x02009;89</th><th align="left" rowspan="1" colspan="1">High &#x00026; exp decrease<sup>&#x02020;</sup>, n&#x02009;=&#x02009;40</th><th align="left" rowspan="1" colspan="1">High &#x00026; exp increase<sup>&#x02020;</sup>, n&#x02009;=&#x02009;9</th><th align="left" rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">MAKE</td><td align="left" rowspan="1" colspan="1">16 (18)</td><td align="left" rowspan="1" colspan="1">16 (40)</td><td align="left" rowspan="1" colspan="1">9 (100)</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Day 7 AKI Stage<sup>a</sup></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;No AKI</td><td align="left" rowspan="1" colspan="1">69 (78)</td><td align="left" rowspan="1" colspan="1">28 (70)</td><td align="left" rowspan="1" colspan="1">1 (11)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 1</td><td align="left" rowspan="1" colspan="1">13 (15)</td><td align="left" rowspan="1" colspan="1">5 (13)</td><td align="left" rowspan="1" colspan="1">1 (11)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 2</td><td align="left" rowspan="1" colspan="1">4 (4)</td><td align="left" rowspan="1" colspan="1">2 (5)</td><td align="left" rowspan="1" colspan="1">1 (11)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Stage 3</td><td align="left" rowspan="1" colspan="1">2 (2)</td><td align="left" rowspan="1" colspan="1">4 (10)</td><td align="left" rowspan="1" colspan="1">4 (44)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Day 1&#x02013;7 AKI Stage change<sup>a</sup></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">0.09</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Improved</td><td align="left" rowspan="1" colspan="1">20 (22)</td><td align="left" rowspan="1" colspan="1">16 (40)</td><td align="left" rowspan="1" colspan="1">2 (22)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Unchanged</td><td align="left" rowspan="1" colspan="1">60 (67)</td><td align="left" rowspan="1" colspan="1">17 (43)</td><td align="left" rowspan="1" colspan="1">4 (44)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Deteriorated</td><td align="left" rowspan="1" colspan="1">8 (9)</td><td align="left" rowspan="1" colspan="1">6 (15)</td><td align="left" rowspan="1" colspan="1">1 (11)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Death</td><td align="left" rowspan="1" colspan="1">8 (9)</td><td align="left" rowspan="1" colspan="1">6 (15)</td><td align="left" rowspan="1" colspan="1">6 (67)</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">RRT</td><td align="left" rowspan="1" colspan="1">3 (3)</td><td align="left" rowspan="1" colspan="1">4 (10)</td><td align="left" rowspan="1" colspan="1">6 (67)</td><td align="left" rowspan="1" colspan="1">&#x02009;&#x0003c;&#x02009;0.001</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140336136150832"><a target="object" rel="noopener" href="/pmc/articles/PMC11156822/table/Tab2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p>NGAL and uL-FABP were log-transformed prior to the analysis</p><p><em>MAKE</em> major adverse kidney events at hospital discharge <em>AKI</em> acute kidney injury <em>RRT</em> renal replacement therapy <em>eGFR</em> estimated glomerular filtration rate <em>NGAL</em> neutrophil gelatinase-associated lipocalin <em>uL-FABP</em> urinary liver-type fatty acid-binding protein</p><p><sup>&#x02020;</sup>&#x0201d;High &#x00026; exp decrease&#x0201d; stands for high and exponential decrease, &#x0201c;High and exp increase&#x0201d; stands for high and exponential increase</p><p><sup>a</sup>For those who had died by day 7, AKI status on day 7 was not defined and was treated as missing value</p></div></div></div><div id="Sec11" class="sec sec-last"><h3 id="Sec11title">Multivariate logistic regression model</h3><p id="Par38" class="p p-first">Table <a href="/pmc/articles/PMC11156822/table/Tab3/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab3" rid-ob="ob-Tab3" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table3</span></span><span>3</span></a> summarizes the logistic regression models for different sets of predictor variables. Both time0 (initial value at time 0&#x000a0;h) and delta12 (change in the first 12&#x000a0;h) of log (uL-FABP) were significantly associated with MAKE, whereas time0 and delta12 of eGFR were not significantly associated with MAKE when included in the model with log (uL-FABP). In the models with time0 and delta12 of eGFR and log (NGAL), no significant association with MAKE was observed. Although the areas under the receiver operating characteristic curves were similar for models including eGFR and log (uL-FABP) as variables of interest (Models 0&#x02013;2), Model 2 (the model including delta12 and time0) showed significant improvement compared with Models 0 and 1, based on the cNRI and IDI (Supplemental Table 1).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="Tab3"><h3>Table&#x000a0;3</h3><!--caption a7--><div class="caption"><p>Multivariate logistic regression models with initial values and 12-h changes for prediction of major adverse kidney events</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" colspan="2" rowspan="1">Model</th><th align="left" rowspan="1" colspan="1">Variable</th><th align="left" rowspan="1" colspan="1">Coefficient</th><th align="left" rowspan="1" colspan="1">SE</th><th align="left" rowspan="1" colspan="1">p-value</th><th align="left" rowspan="1" colspan="1">OR (95% CI)</th></tr></thead><tbody><tr><td align="left" rowspan="9" colspan="1"><p>Models on:</p><p>eGFR,</p><p>log (uL-FABP)</p><p>N&#x02009;=&#x02009;140</p></td><td align="left" rowspan="2" colspan="1">Model 0</td><td align="left" rowspan="1" colspan="1"><strong>eGFR</strong><sub><strong>0</strong></sub></td><td align="left" rowspan="1" colspan="1"><strong>&#x02212;&#x000a0;0.014</strong></td><td align="left" rowspan="1" colspan="1"><strong>0.006</strong></td><td align="left" rowspan="1" colspan="1"><strong>0.03</strong></td><td align="left" rowspan="1" colspan="1"><strong>0.98 (0.97&#x02013;0.99)</strong></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;eGFR</td><td align="left" rowspan="1" colspan="1"><strong>&#x02212;&#x000a0;</strong>0.018</td><td align="left" rowspan="1" colspan="1">0.013</td><td align="left" rowspan="1" colspan="1">0.18</td><td align="left" rowspan="1" colspan="1">0.98 (0.96&#x02013;1.01)</td></tr><tr><td align="left" rowspan="3" colspan="1">Model 1</td><td align="left" rowspan="1" colspan="1">eGFR<sub>0</sub></td><td align="left" rowspan="1" colspan="1"><strong>&#x02212;&#x000a0;</strong>0.009</td><td align="left" rowspan="1" colspan="1">0.007</td><td align="left" rowspan="1" colspan="1">0.20</td><td align="left" rowspan="1" colspan="1">0.99 (0.98&#x02013;1.00)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;eGFR</td><td align="left" rowspan="1" colspan="1"><strong>&#x02212;&#x000a0;</strong>0.015</td><td align="left" rowspan="1" colspan="1">0.013</td><td align="left" rowspan="1" colspan="1">0.27</td><td align="left" rowspan="1" colspan="1">0.99 (0.96&#x02013;1.01)</td></tr><tr><td align="left" rowspan="1" colspan="1"><strong>Log (uL-FABP)</strong><sub><strong>0</strong></sub></td><td align="left" rowspan="1" colspan="1"><strong>0.220</strong></td><td align="left" rowspan="1" colspan="1"><strong>0.094</strong></td><td align="left" rowspan="1" colspan="1"><strong>0.02</strong></td><td align="left" rowspan="1" colspan="1"><strong>1.25 (1.04&#x02013;1.51)</strong></td></tr><tr><td align="left" rowspan="4" colspan="1">Model 2</td><td align="left" rowspan="1" colspan="1">eGFR<sub>0</sub></td><td align="left" rowspan="1" colspan="1"><strong>&#x02212;&#x000a0;</strong>0.004</td><td align="left" rowspan="1" colspan="1">0.006</td><td align="left" rowspan="1" colspan="1">0.48</td><td align="left" rowspan="1" colspan="1">1.00 (0.98&#x02013;1.01)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;eGFR</td><td align="left" rowspan="1" colspan="1"><strong>&#x02212;&#x000a0;</strong>0.015</td><td align="left" rowspan="1" colspan="1">0.013</td><td align="left" rowspan="1" colspan="1">0.25</td><td align="left" rowspan="1" colspan="1">0.99 (0.96&#x02013;1.01)</td></tr><tr><td align="left" rowspan="1" colspan="1"><strong>Log (uL-FABP)</strong><sub><strong>0</strong></sub></td><td align="left" rowspan="1" colspan="1"><strong>0.373</strong></td><td align="left" rowspan="1" colspan="1"><strong>0.114</strong></td><td align="left" rowspan="1" colspan="1"><strong>0.001</strong></td><td align="left" rowspan="1" colspan="1"><strong>1.45 (1.17&#x02013;1.83)</strong></td></tr><tr><td align="left" rowspan="1" colspan="1"><strong>&#x00394;Log (uL-FABP)</strong></td><td align="left" rowspan="1" colspan="1"><strong>0.357</strong></td><td align="left" rowspan="1" colspan="1"><strong>0.131</strong></td><td align="left" rowspan="1" colspan="1"><strong>0.006</strong></td><td align="left" rowspan="1" colspan="1"><strong>1.43 (1.12&#x02013;1.88)</strong></td></tr><tr><td align="left" rowspan="9" colspan="1"><p>Models on:</p><p>eGFR,</p><p>log (NGAL)</p><p>N&#x02009;=&#x02009;146</p></td><td align="left" rowspan="2" colspan="1">Model 0&#x02019;</td><td align="left" rowspan="1" colspan="1"><strong>eGFR</strong><sub><strong>0</strong></sub></td><td align="left" rowspan="1" colspan="1"><strong>&#x02212;&#x000a0;0.014</strong></td><td align="left" rowspan="1" colspan="1"><strong>0.006</strong></td><td align="left" rowspan="1" colspan="1"><strong>0.03</strong></td><td align="left" rowspan="1" colspan="1"><strong>0.98 (0.97&#x02013;1.00)</strong></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;eGFR</td><td align="left" rowspan="1" colspan="1"><strong>&#x02212;&#x000a0;</strong>0.017</td><td align="left" rowspan="1" colspan="1">0.013</td><td align="left" rowspan="1" colspan="1">0.18</td><td align="left" rowspan="1" colspan="1">0.98 (0.96&#x02013;1.01)</td></tr><tr><td align="left" rowspan="3" colspan="1">Model 1&#x02019;</td><td align="left" rowspan="1" colspan="1">eGFR<sub>0</sub></td><td align="left" rowspan="1" colspan="1"><strong>&#x02212;&#x000a0;</strong>0.009</td><td align="left" rowspan="1" colspan="1">0.007</td><td align="left" rowspan="1" colspan="1">0.19</td><td align="left" rowspan="1" colspan="1">0.99 (0.98&#x02013;1.00)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;eGFR</td><td align="left" rowspan="1" colspan="1"><strong>&#x02212;&#x000a0;</strong>0.017</td><td align="left" rowspan="1" colspan="1">0.013</td><td align="left" rowspan="1" colspan="1">0.19</td><td align="left" rowspan="1" colspan="1">0.98 (0.96&#x02013;1.01)</td></tr><tr><td align="left" rowspan="1" colspan="1">Log (NGAL)<sub>0</sub></td><td align="left" rowspan="1" colspan="1">0.255</td><td align="left" rowspan="1" colspan="1">0.214</td><td align="left" rowspan="1" colspan="1">0.23</td><td align="left" rowspan="1" colspan="1">1.29 (0.85&#x02013;1.97)</td></tr><tr><td align="left" rowspan="4" colspan="1">Model 2&#x02019;</td><td align="left" rowspan="1" colspan="1">eGFR<sub>0</sub></td><td align="left" rowspan="1" colspan="1"><strong>&#x02212;&#x000a0;</strong>0.008</td><td align="left" rowspan="1" colspan="1">0.007</td><td align="left" rowspan="1" colspan="1">0.22</td><td align="left" rowspan="1" colspan="1">0.99 (0.98&#x02013;1.00)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;eGFR</td><td align="left" rowspan="1" colspan="1"><strong>&#x02212;&#x000a0;</strong>0.009</td><td align="left" rowspan="1" colspan="1">0.013</td><td align="left" rowspan="1" colspan="1">0.48</td><td align="left" rowspan="1" colspan="1">0.99 (0.96&#x02013;1.02)</td></tr><tr><td align="left" rowspan="1" colspan="1">Log (NGAL)<sub>0</sub></td><td align="left" rowspan="1" colspan="1">0.349</td><td align="left" rowspan="1" colspan="1">0.220</td><td align="left" rowspan="1" colspan="1">0.11</td><td align="left" rowspan="1" colspan="1">1.42 (0.92&#x02013;2.20)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394;Log (NGAL)</td><td align="left" rowspan="1" colspan="1">0.822</td><td align="left" rowspan="1" colspan="1">0.463</td><td align="left" rowspan="1" colspan="1">0.08</td><td align="left" rowspan="1" colspan="1">2.28 (0.93&#x02013;5.79)</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140336134195584"><a target="object" rel="noopener" href="/pmc/articles/PMC11156822/table/Tab3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p>All models were built with major adverse kidney events (MAKE) at hospital discharge as the outcome. Patients with missing values in the variables of interest were excluded from the analysis on those variables. OR was calculated for every 1 unit increase of each variable (for NGAL and uL-FABP, OR for an increase of the log-transformed value by 1 point). Bold values denote statistical significance</p><p><em>SE</em> Standard error, <em>OR</em> Odds ratio, <em>CI</em> Confidence interval, <em>eGFR</em> estimated glomerular filtration rate, <em>NGAL</em> neutrophil gelatinase-associated lipocalin, <em>uL-FABP</em> urinary liver-type fatty acid-binding protein, <em>eGFR</em><sub><em>0</em></sub> initial value of eGFR, <em>&#x00394;eGFR</em> 12-h change of eGFR, <em>Log (uL-FABP)</em><sub><em>0</em></sub> initial value of log (uL-FABP), <em>&#x00394;Log (uL-FABP)</em> 12-h change of log (uL-FABP), <em>Log (NGAL)</em><sub><em>0</em></sub> initial value of log (NGAL), <em>&#x00394;Log (NGAL)</em> 12-h change of log (NGAL)</p></div></div><p id="Par39">Based on these results, FABPi was defined as the fitted value for Model 2. FABPi was calculated using the covariates in Model 2, as shown in the following formula:</p><div class="disp-formula" id="Equa"><div class="f"><math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2" display="block"><mrow><mi>F</mi><mi>A</mi><mi>B</mi><mi>P</mi><mi>i</mi><mo>=</mo><mfrac><mrow><mi>e</mi><mi>x</mi><mi>p</mi><mo stretchy="false">[</mo><mo>-</mo><mn>2.144</mn><mo>-</mo><mn>0.004</mn><mo>&#x000d7;</mo><msub><mrow><mi mathvariant="italic">eGFR</mi></mrow><mn>0</mn></msub><mo>-</mo><mn>0.015</mn><mo>&#x000d7;</mo><mi mathvariant="normal">&#x00394;</mi><mi>e</mi><mi>G</mi><mi>F</mi><mi>R</mi><mo>+</mo><mn>0.373</mn><mo>&#x000d7;</mo><msub><mrow><mi>L</mi><mi>o</mi><mi>g</mi><mfenced close=")" open="("><mi>u</mi><mi>L</mi><mo>-</mo><mi>F</mi><mi>A</mi><mi>B</mi><mi>P</mi></mfenced></mrow><mn>0</mn></msub><mo>+</mo><mn>0.357</mn><mo>&#x000d7;</mo><mi mathvariant="normal">&#x00394;</mi><mi>L</mi><mi>o</mi><mi>g</mi><mfenced close=")" open="("><mi>u</mi><mi>L</mi><mo>-</mo><mi>F</mi><mi>A</mi><mi>B</mi><mi>P</mi></mfenced><mo stretchy="false">]</mo></mrow><mrow><mn>1</mn><mo>+</mo><mi>e</mi><mi>x</mi><mi>p</mi><mo stretchy="false">[</mo><mo>-</mo><mn>2.144</mn><mo>-</mo><mn>0.004</mn><mo>&#x000d7;</mo><msub><mrow><mi mathvariant="italic">eGFR</mi></mrow><mn>0</mn></msub><mo>-</mo><mn>0.015</mn><mo>&#x000d7;</mo><mi mathvariant="normal">&#x00394;</mi><mi>e</mi><mi>G</mi><mi>F</mi><mi>R</mi><mo>+</mo><mn>0.373</mn><mo>&#x000d7;</mo><msub><mrow><mi>L</mi><mi>o</mi><mi>g</mi><mfenced close=")" open="("><mi>u</mi><mi>L</mi><mo>-</mo><mi>F</mi><mi>A</mi><mi>B</mi><mi>P</mi></mfenced></mrow><mn>0</mn></msub><mo>+</mo><mn>0.357</mn><mo>&#x000d7;</mo><mi mathvariant="normal">&#x00394;</mi><mi>L</mi><mi>o</mi><mi>g</mi><mfenced close=")" open="("><mi>u</mi><mi>L</mi><mo>-</mo><mi>F</mi><mi>A</mi><mi>B</mi><mi>P</mi></mfenced><mo stretchy="false">]</mo></mrow></mfrac></mrow></math></div></div><p>where eGFR<sub>0</sub> stands for the initial eGFR value, &#x00394;eGFR stands for the 12-h change in eGFR, log (uL-FABP)<sub>0</sub> stands for the initial value of log (uL-FABP), and &#x00394;log (uL-FABP) stands for the 12-h change in log (uL-FABP).</p><p id="Par40" class="p p-last">The best cutoff of FABPi to predict MAKE was calculated as 0.299 with sensitivity of 0.585 and specificity of 0.778, using Youden index (Supplemental Fig.&#x000a0;4). Supplemental Table 2 shows the clinical characteristics likely to influence MAKE (i.e., potential confounders) before and after balancing using IPW. The standard mean difference for each variable was less than 0.1 in the weighted patient data, suggesting an appropriate balancing. The odds ratio of positive FABPi for MAKE with a 95% confidence interval was calculated as 3.74 (1.52&#x02013;9.19) (p&#x02009;=&#x02009;0.004).</p></div></div><div id="Sec12" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec12title">Discussion</h2><p id="Par41" class="p p-first">In this prospective observational study with serial measurements, the chronological changes (i.e., trajectory) of AKI biomarkers and eGFR were clustered into three subgroups and visualized using group-based trajectory modeling. In one study, this statistical method was used to categorize the trajectory patterns of kidney function over a longer period of years, in the setting of an epidemiological research on chronic kidney health [<a href="#CR35" rid="CR35" class=" bibr popnode">35</a>]. To the best of our knowledge, this is the first study to evaluate the trajectory patterns of AKI biomarkers in ICU patients, in acute settings. The trajectory subcategories showed significant associations with clinical outcomes for eGFR, log (NGAL), and log (uL-FABP); lower eGFR, higher NGAL, and higher uL-FABP were associated with worse outcomes (Fig.&#x000a0;<a href="/pmc/articles/PMC11156822/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3</span></a> and Table&#x000a0;<a href="/pmc/articles/PMC11156822/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span>2</span></a>). These findings are concordant with previous studies showing the association of severity in these renal variables and clinical outcomes [<a href="#CR13" rid="CR13" class=" bibr popnode">13</a>, <a href="#CR15" rid="CR15" class=" bibr popnode">15</a>&#x02013;<a href="#CR24" rid="CR24" class=" bibr popnode">24</a>, <a href="#CR36" rid="CR36" class=" bibr popnode">36</a>, <a href="#CR37" rid="CR37" class=" bibr popnode">37</a>].</p><p id="Par42">A unique finding of this study was the differences in the shape of the trajectory patterns for log (uL-FABP) compared to eGFR and log (NGAL) (Fig.&#x000a0;<a href="/pmc/articles/PMC11156822/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3</span></a>). Both the magnitude and the direction of the chronological changes constituted important characteristics of the trajectory for log (uL-FABP). The association of the unique trajectory patterns for log (uL-FABP) with poor clinical outcomes was demonstrated in a stepwise manner from &#x0201c;low and constant&#x0201d; to &#x0201c;high and exponential increase&#x0201d; (Table&#x000a0;<a href="/pmc/articles/PMC11156822/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span>2</span></a>). In contrast, the trajectory curves of eGFR and log (NGAL) paralleled each other, meaning that the magnitude relationship in eGFR and log (NGAL) did not change during the initial 48&#x000a0;h after ICU admission. These findings suggest that identifying the uL-FABP trajectory pattern by serial measurements may give additional information during the early hours after ICU admission. This may be because uL-FABP reflected tubular damage more accurately than the other two indices. A sustained increase in tubular damage biomarkers might reflect ongoing persistent kidney injury, which add more information on the undergoing pathological process over time, leading to MAKE events. This assumed mechanism supports the result that &#x0201c;high and exponential decrease&#x0201d; uL-FABP trajectory class tended to show higher rate of recovery in AKI severity (supplemental Fig. 2). There seem discrepancies among the trajectory classes of eGFR, log (NGAL), and log (uL-FABP) (supplemental Fig. 3). This may be because uL-FABP was able to reflect kidney damage better than the others. Estimated GFR reflected not kidney damage but kidney function, whereas NGAL in blood might fail to reflect kidney damage.</p><p id="Par43">Another important finding of this study is the integrated model consisting of two different variables for temporal changes in uL-FABP, i.e., time0 and delta 12 (Table&#x000a0;<a href="/pmc/articles/PMC11156822/table/Tab3/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab3" rid-ob="ob-Tab3" co-legend-rid=""><span>3</span></a>). Time0 and delta12 of log (uL-FABP) were significantly associated with MAKE after adjusting for eGFR, whereas time0 and delta12 of log (NGAL) did not significantly associate with MAKE. This suggests that both the initial value (i.e., initial severity) and the early chronological changes (i.e., trend) of log (uL-FABP) may independently impact clinical outcomes, highlighting the importance of trajectory analysis. In one study, patients with increased uL-FABP levels (measured using a semi-quantitative kit) during the initial 6&#x000a0;h after ICU admission had higher mortality rates compared with the mortality rates in patients with decreased or unchanged uL-FABP levels [<a href="#CR23" rid="CR23" class=" bibr popnode">23</a>]. In addition, the binary index (i.e., positive or negative FABPi), based on the best model according to the cNRI and IDI (Supplemental Table 1), significantly associated with MAKE with a high OR [3.74 (1.52&#x02013;9.19)], even after balancing for potential confounders (Supplemental Table 2). In acute clinical settings, such as emergency departments, the acuteness of renal dysfunction is often difficult to determine [<a href="#CR38" rid="CR38" class=" bibr popnode">38</a>] and an information on acute renal damage would be more helpful to make a clinical judgement. Based on the findings of our study, serial uL-FABP measurements in the early clinical course may be helpful in such acute clinical settings.</p><p id="Par44">In this study, biomarkers were measured at time 0, 12, 24, and 48&#x000a0;h after ICU admission. However, the most appropriate timing and frequency of measurements has not been determined. Although more frequent measurements would give more accuracy, this may not be feasible due to an increased medical cost for many measurements. Previous studies showed that uL-FABP may peak within 6&#x000a0;h of cardiac surgery and continue to change for several days [<a href="#CR39" rid="CR39" class=" bibr popnode">39</a>, <a href="#CR40" rid="CR40" class=" bibr popnode">40</a>]. However, in general ICU patients, the peak timing would be less clear than in surgical patients. In addition to the frequency of measurements, the duration of intra-measurements is another issue. Evaluation of changes with longer observation period may enable to predict long term outcomes such as MAKE more accurately.</p><p id="Par45">An observational study reported that changes in plasma NGAL levels during the first 48&#x000a0;h predicted mortality in 50 ICU patients with AKI stage 2 or higher [<a href="#CR41" rid="CR41" class=" bibr popnode">41</a>]. Another observational study showed that NGAL declined more between the 24&#x02013;48-h and 5&#x02013;7-day measurements after ICU admission in patients without MAKE at discharge compared with the patients who developed MAKE [<a href="#CR42" rid="CR42" class=" bibr popnode">42</a>]. In our study, time0 and delta12 of log (NGAL) failed to show a significant association with MAKE in the multivariate logistic regression models (Table&#x000a0;<a href="/pmc/articles/PMC11156822/table/Tab3/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab3" rid-ob="ob-Tab3" co-legend-rid=""><span>3</span></a>). In addition to differences in the biological characteristics of NGAL and L-FABP [<a href="#CR9" rid="CR9" class=" bibr popnode">9</a>, <a href="#CR43" rid="CR43" class=" bibr popnode">43</a>], the optimal timeframe of serial measurements may be different. It is also important to consider the difference between plasma and urine samples. The different findings of NGAL and uL-FABP in our study might be attributable to the difference between plasma and urine, rather than NGAL and L-FABP. It would be one of the interesting future steps, to investigate the clinical characteristics of urinary NGAL and its trajectory patterns. Further evaluation is necessary to determine the best measurement strategy for these biomarkers.</p><p id="Par46" class="p p-last">There are several limitations to this study. First, this is a single-center study and the population may have been biased. In addition, enrollment in this study was limited to patients with an arterial line and a urinary catheter. Although these are common interventions in the ICU, similar findings may not be observed in less severely ill patients without these devices. Thus, caution should be applied when generalizing the results of this study. Second, due to the small sample size, trajectory modeling might miss small trajectory classes and the lack of validation cohort might lead to an overadjustment. Although the confounders in this study were pre-specified, the final sample size was not sufficiently large for a simple multivariate logistic regression analysis with all confounders in one model. Hence, combination of logistic regression and inverse probability weighting was selected in this study. These might be complicated processes and could be a source of overadjustment as well. Third, the number of classes in the trajectory analysis was determined by both mathematical indices such as Bayesian information criterion but also by model interpretability; thus, this method might include some arbitrariness. In addition, it should be noted that there are no established methods to adjust the potential confounders within the trajectory analysis. Although the logistic regression model results are concordant with the results of the trajectory analysis, the overall findings of this study might be influenced by such confounders to some extent. The statistical methods used in this study may have several more limitation. Youden index gives the most &#x0201c;balanced&#x0201d; cutoffs, assuming sensitivity and specificity are equally important. This assumption might not always be true. The interpretation of cNRI is not intuitive and the model selection may be influenced by overfitting. The patients with missing values had to be excluded from the analyses in both the group-based trajectory modeling and logistic regression models. The common reasons for missing values were removal of the arterial lines or the urinary catheter during the study and anuric status, making blood or urine sample collection impossible. However, even in the model with the highest number of excluded patients, 88% of patients were still available for analysis [trajectory model of log (uL-FABP), 138 out of 156 patients]. Lastly, AKI was diagnosed only by sCr in this study. Although the KDIGO AKI diagnostic criteria include UOP information, the clinical indication of sCr and UOP may not be interchangeable. The sCr-based AKI stage was sometimes different from the UOP-based stage, even in the same patient [<a href="#CR44" rid="CR44" class=" bibr popnode">44</a>]. In addition, one study showed that patients with UOP-based AKI stage 3 had a higher mortality rate than sCr-based AKI stage 3 [<a href="#CR45" rid="CR45" class=" bibr popnode">45</a>]. In this study, anuric patients were excluded from the analysis of uL-FABP; thus, extra caution should be applied when interpreting the results.</p></div><div id="Sec13" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec13title">Conclusions</h2><p id="Par47" class="p p-first-last">The trajectory patterns of AKI biomarkers, especially the patterns of uL-FABP changes were significantly associated with MAKE, indicating the importance of the biomarker trajectory in ICU practice. The addition of chronological changes to the initial severity of uL-FABP may contribute to discriminate worsening critically ill patients from others. Further investigation is warranted to develop the clinical management strategy that utilizes biomarker trajectories.</p></div><div id="sec-a.m.f" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="headless nomenu"></h2><!--/article/body/sec/--><div id="Sec14" class="sec sec-first-last"><h3 id="Sec14title">Supplementary Information</h3><p class="p p-first-last">
</p><div class="sec suppmat" id="MOESM1"><div class="sup-box half_rhythm" id="media-a.m.f.a.b.a.a"><a href="/pmc/articles/PMC11156822/bin/13613_2024_1328_MOESM1_ESM.docx" data-ga-action="click_feat_suppl">Supplementary Material 1.</a><sup>(393K, docx)</sup></div></div><div class="sec suppmat" id="MOESM2"><div class="sup-box half_rhythm" id="media-a.m.f.a.b.b.a"><a href="/pmc/articles/PMC11156822/bin/13613_2024_1328_MOESM2_ESM.docx" data-ga-action="click_feat_suppl">Supplementary Material 2.</a><sup>(1.2M, docx)</sup></div></div><div class="sec suppmat" id="MOESM3"><div class="sup-box half_rhythm" id="media-a.m.f.a.b.c.a"><a href="/pmc/articles/PMC11156822/bin/13613_2024_1328_MOESM3_ESM.xlsx" data-ga-action="click_feat_suppl">Supplementary Material 3.</a><sup>(41K, xlsx)</sup></div></div><p></p></div></div><div id="ack-a.n.c" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.n.ctitle">Acknowledgements</h2><div class="sec"><p>The authors would like to thank Ryota Inokuchi for the advice on data analysis and manuscript writing.</p></div></div><div id="glossary-a.n.a" class="tsec sec"><h2 class="head no_bottom_margin" id="glossary-a.n.atitle">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td>AKI</td><td>Acute kidney injury</td></tr><tr><td>ICU</td><td>Intensive care unit</td></tr><tr><td>RRT</td><td>Renal replacement therapy</td></tr><tr><td>CKD</td><td>Chronic kidney disease</td></tr><tr><td>KDIGO</td><td>Kidney Disease: Improving Global Outcomes</td></tr><tr><td>sCr</td><td>Serum creatinine</td></tr><tr><td>UOP</td><td>Urine output</td></tr><tr><td>NGAL</td><td>Neutrophil gelatinase-associated lipocalin</td></tr><tr><td>L-FABP</td><td>Liver-type fatty acid-binding protein</td></tr><tr><td>uL-FABP</td><td>Urine L-FABP</td></tr><tr><td>GBTM</td><td>Group-based trajectory modeling</td></tr><tr><td>MAKE</td><td>Major adverse kidney event</td></tr><tr><td>ESRD</td><td>End-stage renal disease</td></tr><tr><td>eGFR</td><td>Estimated glomerular filtration rate</td></tr><tr><td>MDRD</td><td>Modified Diet Renal Disease</td></tr><tr><td>cNRI</td><td>Continuous net reclassification improvement</td></tr><tr><td>IDI</td><td>Integrated discrimination improvement</td></tr><tr><td>FABPi</td><td>Integrated uL-FABP index</td></tr><tr><td>APACHE II</td><td>Acute physiology and chronic health evaluation II</td></tr><tr><td>IPW</td><td>Inverse probability weighting</td></tr><tr><td>SOFA</td><td>Sequential organ failure assessment</td></tr></tbody></table></div></div></div><div id="notes-a.n.d" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.n.dtitle">Author contributions</h2><p>RH interpreted the patient data, conceived and performed the statistical analysis and wrote the paper. NH, TA, MY, and TM collected the patient data and performed the measurement of AKI biomarkers. KD designed and supervised the data collection and analysis. All authors read and approved the final manuscript.</p></div><div id="notes-a.n.e" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.n.etitle">Funding</h2><p>None.</p></div><div id="notes-a.n.f" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.n.ftitle">Availability of data and materials</h2><p>The dataset supporting the conclusions of this article is included within the article (and its additional file (s)).</p></div><div id="notes-a.n.g" class="tsec sec"><h2 class="head no_bottom_margin" id="notes-a.n.gtitle">Declarations</h2><div>Ethics approval and consent to participate<p id="Par48">The study protocol was approved by the Research Ethics Committee of the Faculty of Medicine of the University of Tokyo (Approval No. 2810-13; title: &#x0201c;Establishment of blood and urinary biomarker for acute kidney injury&#x0201d; on December 7, 2009). Written informed consent was obtained from the patient or surrogate decision maker.</p></div><div>Consent for publication<p id="Par49">Not applicable.</p></div><div>Competing interests<p id="Par50">The authors have no conflicts of interest to declare.</p></div></div><div id="fn-group-a.n.b" class="tsec sec"><h2 class="head no_bottom_margin" id="fn-group-a.n.btitle">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="fn-a.n.b.a"><p class="p p-first"><strong>Publisher's Note</strong></p><p class="p p-last">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></p></div></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, et al. World incidence of AKI: a meta-analysis. <span><span class="ref-journal">Clin J Am Soc Nephrol. </span>2013;<span class="ref-vol">8</span>(9):1482–1493. doi: 10.2215/CJN.00710113.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3805065/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23744003" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2215%2FCJN.00710113" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+J+Am+Soc+Nephrol&amp;title=World+incidence+of+AKI:+a+meta-analysis&amp;author=P+Susantitaphong&amp;author=DN+Cruz&amp;author=J+Cerda&amp;author=M+Abulfaraj&amp;author=F+Alqahtani&amp;volume=8&amp;issue=9&amp;publication_year=2013&amp;pages=1482-1493&amp;pmid=23744003&amp;doi=10.2215/CJN.00710113&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. <span><span class="ref-journal">Intensive Care Med. </span>2015;<span class="ref-vol">41</span>(8):1411–1423. doi: 10.1007/s00134-015-3934-7.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26162677" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00134-015-3934-7" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Intensive+Care+Med&amp;title=Epidemiology+of+acute+kidney+injury+in+critically+ill+patients:+the+multinational+AKI-EPI+study&amp;author=EA+Hoste&amp;author=SM+Bagshaw&amp;author=R+Bellomo&amp;author=CM+Cely&amp;author=R+Colman&amp;volume=41&amp;issue=8&amp;publication_year=2015&amp;pages=1411-1423&amp;pmid=26162677&amp;doi=10.1007/s00134-015-3934-7&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Trongtrakul K, Sawawiboon C, Wang AY, Chitsomkasem A, Limphunudom P, Kurathong S, et al. Acute kidney injury in critically ill surgical patients: epidemiology, risk factors and outcomes. <span><span class="ref-journal">Nephrology (Carlton) </span>2019;<span class="ref-vol">24</span>(1):39–46. doi: 10.1111/nep.13192.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29124867" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fnep.13192" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nephrology+(Carlton)&amp;title=Acute+kidney+injury+in+critically+ill+surgical+patients:+epidemiology,+risk+factors+and+outcomes&amp;author=K+Trongtrakul&amp;author=C+Sawawiboon&amp;author=AY+Wang&amp;author=A+Chitsomkasem&amp;author=P+Limphunudom&amp;volume=24&amp;issue=1&amp;publication_year=2019&amp;pages=39-46&amp;pmid=29124867&amp;doi=10.1111/nep.13192&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Peerapornratana S, Manrique-Caballero CL, G&#x000f3;mez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. <span><span class="ref-journal">Kidney Int. </span>2019;<span class="ref-vol">96</span>(5):1083–1099. doi: 10.1016/j.kint.2019.05.026.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6920048/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31443997" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.kint.2019.05.026" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Acute+kidney+injury+from+sepsis:+current+concepts,+epidemiology,+pathophysiology,+prevention+and+treatment&amp;author=S+Peerapornratana&amp;author=CL+Manrique-Caballero&amp;author=H+G&#x000f3;mez&amp;author=JA+Kellum&amp;volume=96&amp;issue=5&amp;publication_year=2019&amp;pages=1083-1099&amp;pmid=31443997&amp;doi=10.1016/j.kint.2019.05.026&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Fujii T, Uchino S, Doi K, Sato T, Kawamura T. Diagnosis, management, and prognosis of patients with acute kidney injury in Japanese intensive care units: The JAKID study. <span><span class="ref-journal">J Crit Care. </span>2018;<span class="ref-vol">47</span>:185–191. doi: 10.1016/j.jcrc.2018.07.007.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30015288" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jcrc.2018.07.007" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Crit+Care&amp;title=Diagnosis,+management,+and+prognosis+of+patients+with+acute+kidney+injury+in+Japanese+intensive+care+units:+The+JAKID+study&amp;author=T+Fujii&amp;author=S+Uchino&amp;author=K+Doi&amp;author=T+Sato&amp;author=T+Kawamura&amp;volume=47&amp;publication_year=2018&amp;pages=185-191&amp;pmid=30015288&amp;doi=10.1016/j.jcrc.2018.07.007&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. <span><span class="ref-journal">Kidney Int. </span>2012;<span class="ref-vol">81</span>(5):442–448. doi: 10.1038/ki.2011.379.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3788581/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22113526" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fki.2011.379" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Chronic+kidney+disease+after+acute+kidney+injury:+a+systematic+review+and+meta-analysis&amp;author=SG+Coca&amp;author=S+Singanamala&amp;author=CR+Parikh&amp;volume=81&amp;issue=5&amp;publication_year=2012&amp;pages=442-448&amp;pmid=22113526&amp;doi=10.1038/ki.2011.379&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Challiner R, Ritchie JP, Fullwood C, Loughnan P, Hutchison AJ. Incidence and consequence of acute kidney injury in unselected emergency admissions to a large acute UK hospital trust. <span><span class="ref-journal">BMC Nephrol. </span>2014;<span class="ref-vol">15</span>:84. doi: 10.1186/1471-2369-15-84.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4046061/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24885247" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1186%2F1471-2369-15-84" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Nephrol&amp;title=Incidence+and+consequence+of+acute+kidney+injury+in+unselected+emergency+admissions+to+a+large+acute+UK+hospital+trust&amp;author=R+Challiner&amp;author=JP+Ritchie&amp;author=C+Fullwood&amp;author=P+Loughnan&amp;author=AJ+Hutchison&amp;volume=15&amp;publication_year=2014&amp;pages=84&amp;pmid=24885247&amp;doi=10.1186/1471-2369-15-84&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Soto K, Campos P, Pinto I, Rodrigues B, Frade F, Papoila AL, et al. The risk of chronic kidney disease and mortality are increased after community-acquired acute kidney injury. <span><span class="ref-journal">Kidney Int. </span>2016;<span class="ref-vol">90</span>(5):1090–1099. doi: 10.1016/j.kint.2016.07.018.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5094192/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27658322" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.kint.2016.07.018" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=The+risk+of+chronic+kidney+disease+and+mortality+are+increased+after+community-acquired+acute+kidney+injury&amp;author=K+Soto&amp;author=P+Campos&amp;author=I+Pinto&amp;author=B+Rodrigues&amp;author=F+Frade&amp;volume=90&amp;issue=5&amp;publication_year=2016&amp;pages=1090-1099&amp;pmid=27658322&amp;doi=10.1016/j.kint.2016.07.018&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Kellum JA, Ronco C, Bellomo R. Conceptual advances and evolving terminology in acute kidney disease. <span><span class="ref-journal">Nat Rev Nephrol. </span>2021;<span class="ref-vol">17</span>(7):493–502. doi: 10.1038/s41581-021-00410-w.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33712812" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41581-021-00410-w" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Nephrol&amp;title=Conceptual+advances+and+evolving+terminology+in+acute+kidney+disease&amp;author=JA+Kellum&amp;author=C+Ronco&amp;author=R+Bellomo&amp;volume=17&amp;issue=7&amp;publication_year=2021&amp;pages=493-502&amp;pmid=33712812&amp;doi=10.1038/s41581-021-00410-w&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. <span><span class="ref-journal">Nephron Clin Pract. </span>2012;<span class="ref-vol">120</span>(4):c179–c184. doi: 10.1159/000339789.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22890468" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1159%2F000339789" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nephron+Clin+Pract&amp;title=KDIGO+clinical+practice+guidelines+for+acute+kidney+injury&amp;author=A+Khwaja&amp;volume=120&amp;issue=4&amp;publication_year=2012&amp;pages=c179-c184&amp;pmid=22890468&amp;doi=10.1159/000339789&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Rizvi MS, Kashani KB. Biomarkers for early detection of acute kidney injury. <span><span class="ref-journal">J Appl Lab Med. </span>2017;<span class="ref-vol">2</span>(3):386–399. doi: 10.1373/jalm.2017.023325.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33636842" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1373%2Fjalm.2017.023325" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Appl+Lab+Med&amp;title=Biomarkers+for+early+detection+of+acute+kidney+injury&amp;author=MS+Rizvi&amp;author=KB+Kashani&amp;volume=2&amp;issue=3&amp;publication_year=2017&amp;pages=386-399&amp;pmid=33636842&amp;doi=10.1373/jalm.2017.023325&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Schrezenmeier EV, Barasch J, Budde K, Westhoff T, Schmidt-Ott KM. Biomarkers in acute kidney injury&#x02014;pathophysiological basis and clinical performance. <span><span class="ref-journal">Acta Physiol (Oxf) </span>2017;<span class="ref-vol">219</span>(3):554–572. doi: 10.1111/apha.12764.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5575831/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27474473" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1111%2Fapha.12764" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Physiol+(Oxf)&amp;title=Biomarkers+in+acute+kidney+injury&#x02014;pathophysiological+basis+and+clinical+performance&amp;author=EV+Schrezenmeier&amp;author=J+Barasch&amp;author=K+Budde&amp;author=T+Westhoff&amp;author=KM+Schmidt-Ott&amp;volume=219&amp;issue=3&amp;publication_year=2017&amp;pages=554-572&amp;pmid=27474473&amp;doi=10.1111/apha.12764&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. <span><span class="ref-journal">J Am Coll Cardiol. </span>2011;<span class="ref-vol">57</span>(17):1752–1761. doi: 10.1016/j.jacc.2010.11.051.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4866647/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21511111" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jacc.2010.11.051" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Coll+Cardiol&amp;title=The+outcome+of+neutrophil+gelatinase-associated+lipocalin-positive+subclinical+acute+kidney+injury:+a+multicenter+pooled+analysis+of+prospective+studies&amp;author=M+Haase&amp;author=P+Devarajan&amp;author=A+Haase-Fielitz&amp;author=R+Bellomo&amp;author=DN+Cruz&amp;volume=57&amp;issue=17&amp;publication_year=2011&amp;pages=1752-1761&amp;pmid=21511111&amp;doi=10.1016/j.jacc.2010.11.051&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Obata Y, Kamijo-Ikemori A, Ichikawa D, Sugaya T, Kimura K, Shibagaki Y, et al. Clinical usefulness of urinary liver-type fatty-acid-binding protein as a perioperative marker of acute kidney injury in patients undergoing endovascular or open-abdominal aortic aneurysm repair. <span><span class="ref-journal">J Anesth. </span>2016;<span class="ref-vol">30</span>(1):89–99. doi: 10.1007/s00540-015-2095-8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4750552/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26585768" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1007%2Fs00540-015-2095-8" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Anesth&amp;title=Clinical+usefulness+of+urinary+liver-type+fatty-acid-binding+protein+as+a+perioperative+marker+of+acute+kidney+injury+in+patients+undergoing+endovascular+or+open-abdominal+aortic+aneurysm+repair&amp;author=Y+Obata&amp;author=A+Kamijo-Ikemori&amp;author=D+Ichikawa&amp;author=T+Sugaya&amp;author=K+Kimura&amp;volume=30&amp;issue=1&amp;publication_year=2016&amp;pages=89-99&amp;pmid=26585768&amp;doi=10.1007/s00540-015-2095-8&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Srisawat N, Murugan R, Lee M, Kong L, Carter M, Angus DC, et al. Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. <span><span class="ref-journal">Kidney Int. </span>2011;<span class="ref-vol">80</span>(5):545–552. doi: 10.1038/ki.2011.160.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3257035/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21677634" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fki.2011.160" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Plasma+neutrophil+gelatinase-associated+lipocalin+predicts+recovery+from+acute+kidney+injury+following+community-acquired+pneumonia&amp;author=N+Srisawat&amp;author=R+Murugan&amp;author=M+Lee&amp;author=L+Kong&amp;author=M+Carter&amp;volume=80&amp;issue=5&amp;publication_year=2011&amp;pages=545-552&amp;pmid=21677634&amp;doi=10.1038/ki.2011.160&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Ito M, Doi K, Takahashi M, Koyama K, Myojo M, Hosoya Y, et al. Plasma neutrophil gelatinase-associated lipocalin predicts major adverse cardiovascular events after cardiac care unit discharge. <span><span class="ref-journal">J Cardiol. </span>2016;<span class="ref-vol">67</span>(2):184–191. doi: 10.1016/j.jjcc.2015.05.010.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26228001" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jjcc.2015.05.010" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cardiol&amp;title=Plasma+neutrophil+gelatinase-associated+lipocalin+predicts+major+adverse+cardiovascular+events+after+cardiac+care+unit+discharge&amp;author=M+Ito&amp;author=K+Doi&amp;author=M+Takahashi&amp;author=K+Koyama&amp;author=M+Myojo&amp;volume=67&amp;issue=2&amp;publication_year=2016&amp;pages=184-191&amp;pmid=26228001&amp;doi=10.1016/j.jjcc.2015.05.010&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">D&#x000e9;pret F, Boutin L, Jarkovsk&#x000fd; J, Chaussard M, Soussi S, Bataille A, et al. Prediction of major adverse kidney events in critically ill burn patients. <span><span class="ref-journal">Burns. </span>2018;<span class="ref-vol">44</span>(8):1887–1894. doi: 10.1016/j.burns.2018.08.007.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30322739" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.burns.2018.08.007" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Burns&amp;title=Prediction+of+major+adverse+kidney+events+in+critically+ill+burn+patients&amp;author=F+D&#x000e9;pret&amp;author=L+Boutin&amp;author=J+Jarkovsk&#x000fd;&amp;author=M+Chaussard&amp;author=S+Soussi&amp;volume=44&amp;issue=8&amp;publication_year=2018&amp;pages=1887-1894&amp;pmid=30322739&amp;doi=10.1016/j.burns.2018.08.007&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Lumlertgul N, Amprai M, Tachaboon S, Dinhuzen J, Peerapornratana S, Kerr SJ, et al. Urine neutrophil gelatinase-associated lipocalin (NGAL) for prediction of persistent AKI and major adverse kidney events. <span><span class="ref-journal">Sci Rep. </span>2020;<span class="ref-vol">10</span>(1):8718. doi: 10.1038/s41598-020-65764-w.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7250906/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32457335" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41598-020-65764-w" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Rep&amp;title=Urine+neutrophil+gelatinase-associated+lipocalin+(NGAL)+for+prediction+of+persistent+AKI+and+major+adverse+kidney+events&amp;author=N+Lumlertgul&amp;author=M+Amprai&amp;author=S+Tachaboon&amp;author=J+Dinhuzen&amp;author=S+Peerapornratana&amp;volume=10&amp;issue=1&amp;publication_year=2020&amp;pages=8718&amp;pmid=32457335&amp;doi=10.1038/s41598-020-65764-w&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Albert C, Haase M, Albert A, Ernst M, Kropf S, Bellomo R, et al. Predictive value of plasma NGAL:hepcidin-25 for major adverse kidney events after cardiac surgery with cardiopulmonary bypass: a pilot study. <span><span class="ref-journal">Ann Lab Med. </span>2021;<span class="ref-vol">41</span>(4):357–365. doi: 10.3343/alm.2021.41.4.357.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7884201/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33536353" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3343%2Falm.2021.41.4.357" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Lab+Med&amp;title=Predictive+value+of+plasma+NGAL:hepcidin-25+for+major+adverse+kidney+events+after+cardiac+surgery+with+cardiopulmonary+bypass:+a+pilot+study&amp;author=C+Albert&amp;author=M+Haase&amp;author=A+Albert&amp;author=M+Ernst&amp;author=S+Kropf&amp;volume=41&amp;issue=4&amp;publication_year=2021&amp;pages=357-365&amp;pmid=33536353&amp;doi=10.3343/alm.2021.41.4.357&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Doi K, Noiri E, Maeda-Mamiya R, Ishii T, Negishi K, Hamasaki Y, et al. Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. <span><span class="ref-journal">Crit Care Med. </span>2010;<span class="ref-vol">38</span>(10):2037–2042. doi: 10.1097/CCM.0b013e3181eedac0.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20657273" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1097%2FCCM.0b013e3181eedac0" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care+Med&amp;title=Urinary+L-type+fatty+acid-binding+protein+as+a+new+biomarker+of+sepsis+complicated+with+acute+kidney+injury&amp;author=K+Doi&amp;author=E+Noiri&amp;author=R+Maeda-Mamiya&amp;author=T+Ishii&amp;author=K+Negishi&amp;volume=38&amp;issue=10&amp;publication_year=2010&amp;pages=2037-2042&amp;pmid=20657273&amp;doi=10.1097/CCM.0b013e3181eedac0&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Hiruma T, Asada T, Yamamoto M, Inokuchi R, Matsubara T, Ishii T, et al. Mortality prediction by acute kidney injury biomarkers in comparison with serum creatinine. <span><span class="ref-journal">Biomarkers. </span>2014;<span class="ref-vol">19</span>(8):646–651. doi: 10.3109/1354750X.2014.968209.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25271041" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.3109%2F1354750X.2014.968209" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomarkers&amp;title=Mortality+prediction+by+acute+kidney+injury+biomarkers+in+comparison+with+serum+creatinine&amp;author=T+Hiruma&amp;author=T+Asada&amp;author=M+Yamamoto&amp;author=R+Inokuchi&amp;author=T+Matsubara&amp;volume=19&amp;issue=8&amp;publication_year=2014&amp;pages=646-651&amp;pmid=25271041&amp;doi=10.3109/1354750X.2014.968209&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Parr SK, Clark AJ, Bian A, Shintani AK, Wickersham NE, Ware LB, et al. Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury. <span><span class="ref-journal">Kidney Int. </span>2015;<span class="ref-vol">87</span>(3):640–648. doi: 10.1038/ki.2014.301.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4344867/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25229339" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fki.2014.301" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Urinary+L-FABP+predicts+poor+outcomes+in+critically+ill+patients+with+early+acute+kidney+injury&amp;author=SK+Parr&amp;author=AJ+Clark&amp;author=A+Bian&amp;author=AK+Shintani&amp;author=NE+Wickersham&amp;volume=87&amp;issue=3&amp;publication_year=2015&amp;pages=640-648&amp;pmid=25229339&amp;doi=10.1038/ki.2014.301&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Suzuki G, Ichibayashi R, Yamamoto S, Serizawa H, Nakamichi Y, Watanabe M, et al. Urinary liver-type fatty acid-binding protein variation as a predictive value of short-term mortality in intensive care unit patients. <span><span class="ref-journal">Ren Fail. </span>2021;<span class="ref-vol">43</span>(1):1041–1048. doi: 10.1080/0886022X.2021.1943439.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8253184/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34187294" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1080%2F0886022X.2021.1943439" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ren+Fail&amp;title=Urinary+liver-type+fatty+acid-binding+protein+variation+as+a+predictive+value+of+short-term+mortality+in+intensive+care+unit+patients&amp;author=G+Suzuki&amp;author=R+Ichibayashi&amp;author=S+Yamamoto&amp;author=H+Serizawa&amp;author=Y+Nakamichi&amp;volume=43&amp;issue=1&amp;publication_year=2021&amp;pages=1041-1048&amp;pmid=34187294&amp;doi=10.1080/0886022X.2021.1943439&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Pan HC, Huang TT, Huang CT, Sun CY, Chen YM, Wu VC. Urinary biomarkers can predict weaning from acute dialysis therapy in critically ill patients. <span><span class="ref-journal">Arch Pathol Lab Med. </span>2022 doi: 10.5858/arpa.2021-0411-OA.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35311928" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.5858%2Farpa.2021-0411-OA" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Pathol+Lab+Med&amp;title=Urinary+biomarkers+can+predict+weaning+from+acute+dialysis+therapy+in+critically+ill+patients&amp;author=HC+Pan&amp;author=TT+Huang&amp;author=CT+Huang&amp;author=CY+Sun&amp;author=YM+Chen&amp;publication_year=2022&amp;pmid=35311928&amp;doi=10.5858/arpa.2021-0411-OA&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Ostermann M, Bellomo R, Burdmann EA, Doi K, Endre ZH, Goldstein SL, et al. Controversies in acute kidney injury: conclusions from a kidney disease: improving global outcomes (KDIGO) conference. <span><span class="ref-journal">Kidney Int. </span>2020;<span class="ref-vol">98</span>(2):294–309. doi: 10.1016/j.kint.2020.04.020.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8481001/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32709292" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.kint.2020.04.020" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Controversies+in+acute+kidney+injury:+conclusions+from+a+kidney+disease:+improving+global+outcomes+(KDIGO)+conference&amp;author=M+Ostermann&amp;author=R+Bellomo&amp;author=EA+Burdmann&amp;author=K+Doi&amp;author=ZH+Endre&amp;volume=98&amp;issue=2&amp;publication_year=2020&amp;pages=294-309&amp;pmid=32709292&amp;doi=10.1016/j.kint.2020.04.020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Prowle JR, Artigas A, Bagshaw SM, Forni LG, Heung M, Hoste E, et al. Serial urinary C-C motif chemokine ligand 14 and risk of persistent severe acute kidney injury. <span><span class="ref-journal">Crit Care Explor. </span>2023;<span class="ref-vol">5</span>(3):e0870. doi: 10.1097/CCE.0000000000000870.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9981369/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36875557" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1097%2FCCE.0000000000000870" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Crit+Care+Explor&amp;title=Serial+urinary+C-C+motif+chemokine+ligand+14+and+risk+of+persistent+severe+acute+kidney+injury&amp;author=JR+Prowle&amp;author=A+Artigas&amp;author=SM+Bagshaw&amp;author=LG+Forni&amp;author=M+Heung&amp;volume=5&amp;issue=3&amp;publication_year=2023&amp;pages=e0870&amp;pmid=36875557&amp;doi=10.1097/CCE.0000000000000870&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Fiorentino M, Xu Z, Smith A, Singbartl K, Palevsky PM, Chawla LS, et al. Serial measurement of cell-cycle arrest biomarkers [TIMP-2] &#x000b7; [IGFBP7] and risk for progression to death, dialysis, or severe acute kidney injury in patients with septic shock. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2020;<span class="ref-vol">202</span>(9):1262–1270. doi: 10.1164/rccm.201906-1197OC.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7605192/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32584598" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1164%2Frccm.201906-1197OC" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Serial+measurement+of+cell-cycle+arrest+biomarkers+[TIMP-2]+&#x000b7;+[IGFBP7]+and+risk+for+progression+to+death,+dialysis,+or+severe+acute+kidney+injury+in+patients+with+septic+shock&amp;author=M+Fiorentino&amp;author=Z+Xu&amp;author=A+Smith&amp;author=K+Singbartl&amp;author=PM+Palevsky&amp;volume=202&amp;issue=9&amp;publication_year=2020&amp;pages=1262-1270&amp;pmid=32584598&amp;doi=10.1164/rccm.201906-1197OC&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">McCullough PA, Ostermann M, Forni LG, Bihorac A, Koyner JL, Chawla LS, et al. Serial urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 and the prognosis for acute kidney injury over the course of critical illness. <span><span class="ref-journal">Cardiorenal Med. </span>2019;<span class="ref-vol">9</span>(6):358–369. doi: 10.1159/000502837.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31618746" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1159%2F000502837" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cardiorenal+Med&amp;title=Serial+urinary+tissue+inhibitor+of+metalloproteinase-2+and+insulin-like+growth+factor-binding+protein+7+and+the+prognosis+for+acute+kidney+injury+over+the+course+of+critical+illness&amp;author=PA+McCullough&amp;author=M+Ostermann&amp;author=LG+Forni&amp;author=A+Bihorac&amp;author=JL+Koyner&amp;volume=9&amp;issue=6&amp;publication_year=2019&amp;pages=358-369&amp;pmid=31618746&amp;doi=10.1159/000502837&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Isshiki R, Asada T, Sumida M, Hamasaki Y, Nangaku M, Noiri E, et al. Modest impact of serial measurements of acute kidney injury biomarkers in an adult intensive care unit. <span><span class="ref-journal">Nephron. </span>2018;<span class="ref-vol">139</span>(3):243–253. doi: 10.1159/000488219.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29614509" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1159%2F000488219" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nephron&amp;title=Modest+impact+of+serial+measurements+of+acute+kidney+injury+biomarkers+in+an+adult+intensive+care+unit&amp;author=R+Isshiki&amp;author=T+Asada&amp;author=M+Sumida&amp;author=Y+Hamasaki&amp;author=M+Nangaku&amp;volume=139&amp;issue=3&amp;publication_year=2018&amp;pages=243-253&amp;pmid=29614509&amp;doi=10.1159/000488219&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. <span><span class="ref-journal">Annu Rev Clin Psychol. </span>2010;<span class="ref-vol">6</span>:109–138. doi: 10.1146/annurev.clinpsy.121208.131413.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20192788" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1146%2Fannurev.clinpsy.121208.131413" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Clin+Psychol&amp;title=Group-based+trajectory+modeling+in+clinical+research&amp;author=DS+Nagin&amp;author=CL+Odgers&amp;volume=6&amp;publication_year=2010&amp;pages=109-138&amp;pmid=20192788&amp;doi=10.1146/annurev.clinpsy.121208.131413&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Nguena Nguefack HL, Pag&#x000e9; MG, Katz J, Choini&#x000e8;re M, Vanasse A, Dorais M, et al. Trajectory modelling techniques useful to epidemiological research: a comparative narrative review of approaches. <span><span class="ref-journal">Clin Epidemiol. </span>2020;<span class="ref-vol">12</span>:1205–1222. doi: 10.2147/CLEP.S265287.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7608582/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33154677" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2147%2FCLEP.S265287" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Epidemiol&amp;title=Trajectory+modelling+techniques+useful+to+epidemiological+research:+a+comparative+narrative+review+of+approaches&amp;author=HL+Nguena+Nguefack&amp;author=MG+Pag&#x000e9;&amp;author=J+Katz&amp;author=M+Choini&#x000e8;re&amp;author=A+Vanasse&amp;volume=12&amp;publication_year=2020&amp;pages=1205-1222&amp;pmid=33154677&amp;doi=10.2147/CLEP.S265287&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">Lennon H, Kelly S, Sperrin M, Buchan I, Cross AJ, Leitzmann M, et al. Framework to construct and interpret latent class trajectory modelling. <span><span class="ref-journal">BMJ Open. </span>2018;<span class="ref-vol">8</span>(7):e020683. doi: 10.1136/bmjopen-2017-020683.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6042544/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29982203" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1136%2Fbmjopen-2017-020683" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMJ+Open&amp;title=Framework+to+construct+and+interpret+latent+class+trajectory+modelling&amp;author=H+Lennon&amp;author=S+Kelly&amp;author=M+Sperrin&amp;author=I+Buchan&amp;author=AJ+Cross&amp;volume=8&amp;issue=7&amp;publication_year=2018&amp;pages=e020683&amp;pmid=29982203&amp;doi=10.1136/bmjopen-2017-020683&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Billings FTT, Shaw AD. Clinical trial endpoints in acute kidney injury. <span><span class="ref-journal">Nephron Clin Pract. </span>2014;<span class="ref-vol">127</span>(1&#x02013;4):89–93. doi: 10.1159/000363725.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4480222/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25343828" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1159%2F000363725" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nephron+Clin+Pract&amp;title=Clinical+trial+endpoints+in+acute+kidney+injury&amp;author=FTT+Billings&amp;author=AD+Shaw&amp;volume=127&amp;issue=1&#x02013;4&amp;publication_year=2014&amp;pages=89-93&amp;pmid=25343828&amp;doi=10.1159/000363725&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. <span><span class="ref-journal">Am J Kidney Dis. </span>2009;<span class="ref-vol">53</span>(6):982–992. doi: 10.1053/j.ajkd.2008.12.034.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19339088" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1053%2Fj.ajkd.2008.12.034" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Kidney+Dis&amp;title=Revised+equations+for+estimated+GFR+from+serum+creatinine+in+Japan&amp;author=S+Matsuo&amp;author=E+Imai&amp;author=M+Horio&amp;author=Y+Yasuda&amp;author=K+Tomita&amp;volume=53&amp;issue=6&amp;publication_year=2009&amp;pages=982-992&amp;pmid=19339088&amp;doi=10.1053/j.ajkd.2008.12.034&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Guiney H, Walker R, Broadbent J, Caspi A, Goodin E, Kokaua J, et al. Kidney-function trajectories from young adulthood to midlife: identifying risk strata and opportunities for intervention. <span><span class="ref-journal">Kidney Int Rep. </span>2023;<span class="ref-vol">8</span>(1):51–63. doi: 10.1016/j.ekir.2022.10.005.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9831942/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/36644353" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.ekir.2022.10.005" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int+Rep&amp;title=Kidney-function+trajectories+from+young+adulthood+to+midlife:+identifying+risk+strata+and+opportunities+for+intervention&amp;author=H+Guiney&amp;author=R+Walker&amp;author=J+Broadbent&amp;author=A+Caspi&amp;author=E+Goodin&amp;volume=8&amp;issue=1&amp;publication_year=2023&amp;pages=51-63&amp;pmid=36644353&amp;doi=10.1016/j.ekir.2022.10.005&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Haas L, Eckart A, Haubitz S, Mueller B, Schuetz P, Segerer S. Estimated glomerular filtration rate predicts 30-day mortality in medical emergency departments: results of a prospective multi-national observational study. <span><span class="ref-journal">PLoS ONE. </span>2020;<span class="ref-vol">15</span>(4):e0230998. doi: 10.1371/journal.pone.0230998.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7135226/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32251482" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pone.0230998" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Estimated+glomerular+filtration+rate+predicts+30-day+mortality+in+medical+emergency+departments:+results+of+a+prospective+multi-national+observational+study&amp;author=L+Haas&amp;author=A+Eckart&amp;author=S+Haubitz&amp;author=B+Mueller&amp;author=P+Schuetz&amp;volume=15&amp;issue=4&amp;publication_year=2020&amp;pages=e0230998&amp;pmid=32251482&amp;doi=10.1371/journal.pone.0230998&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">Suk CW, Hsu SC, Chen CY, Hsieh HL, Kuo HT, Hsu YP, et al. Point of care eGFR and the prediction of outcomes in pneumonia. <span><span class="ref-journal">Sci Rep. </span>2019;<span class="ref-vol">9</span>(1):8478. doi: 10.1038/s41598-019-44945-2.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6559990/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31186488" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fs41598-019-44945-2" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Rep&amp;title=Point+of+care+eGFR+and+the+prediction+of+outcomes+in+pneumonia&amp;author=CW+Suk&amp;author=SC+Hsu&amp;author=CY+Chen&amp;author=HL+Hsieh&amp;author=HT+Kuo&amp;volume=9&amp;issue=1&amp;publication_year=2019&amp;pages=8478&amp;pmid=31186488&amp;doi=10.1038/s41598-019-44945-2&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Horie R, Endo Y, Doi K. Estimated glomerular filtration rate may be an independent predictor for clinical outcomes regardless of acute kidney injury complication in the emergency department. <span><span class="ref-journal">PLoS ONE. </span>2021;<span class="ref-vol">16</span>(10):e0258665. doi: 10.1371/journal.pone.0258665.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8516290/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34648576" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1371%2Fjournal.pone.0258665" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Estimated+glomerular+filtration+rate+may+be+an+independent+predictor+for+clinical+outcomes+regardless+of+acute+kidney+injury+complication+in+the+emergency+department&amp;author=R+Horie&amp;author=Y+Endo&amp;author=K+Doi&amp;volume=16&amp;issue=10&amp;publication_year=2021&amp;pages=e0258665&amp;pmid=34648576&amp;doi=10.1371/journal.pone.0258665&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Parikh CR, Thiessen-Philbrook H, Garg AX, Kadiyala D, Shlipak MG, Koyner JL, et al. Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. <span><span class="ref-journal">Clin J Am Soc Nephrol. </span>2013;<span class="ref-vol">8</span>(7):1079–1088. doi: 10.2215/CJN.10971012.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3700701/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23599408" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.2215%2FCJN.10971012" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+J+Am+Soc+Nephrol&amp;title=Performance+of+kidney+injury+molecule-1+and+liver+fatty+acid-binding+protein+and+combined+biomarkers+of+AKI+after+cardiac+surgery&amp;author=CR+Parikh&amp;author=H+Thiessen-Philbrook&amp;author=AX+Garg&amp;author=D+Kadiyala&amp;author=MG+Shlipak&amp;volume=8&amp;issue=7&amp;publication_year=2013&amp;pages=1079-1088&amp;pmid=23599408&amp;doi=10.2215/CJN.10971012&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="element-citation">Peco-Anti&#x00107; A, Ivani&#x00161;evi&#x00107; I, Vuli&#x00107;evi&#x00107; I, Kotur-Stevuljevi&#x00107; J, Ili&#x00107; S, Ivani&#x00161;evi&#x00107; J, et al. Biomarkers of acute kidney injury in pediatric cardiac surgery. <span><span class="ref-journal">Clin Biochem. </span>2013;<span class="ref-vol">46</span>(13&#x02013;14):1244–1251. doi: 10.1016/j.clinbiochem.2013.07.008.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23876402" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.clinbiochem.2013.07.008" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Biochem&amp;title=Biomarkers+of+acute+kidney+injury+in+pediatric+cardiac+surgery&amp;author=A+Peco-Anti&#x00107;&amp;author=I+Ivani&#x00161;evi&#x00107;&amp;author=I+Vuli&#x00107;evi&#x00107;&amp;author=J+Kotur-Stevuljevi&#x00107;&amp;author=S+Ili&#x00107;&amp;volume=46&amp;issue=13&#x02013;14&amp;publication_year=2013&amp;pages=1244-1251&amp;pmid=23876402&amp;doi=10.1016/j.clinbiochem.2013.07.008&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR41">41. <span class="element-citation">Mahmoodpoor A, Hamishehkar H, Fattahi V, Sanaie S, Arora P, Nader ND. Urinary versus plasma neutrophil gelatinase-associated lipocalin (NGAL) as a predictor of mortality for acute kidney injury in intensive care unit patients. <span><span class="ref-journal">J Clin Anesth. </span>2018;<span class="ref-vol">44</span>:12–17. doi: 10.1016/j.jclinane.2017.10.010.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29100016" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1016%2Fj.jclinane.2017.10.010" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Anesth&amp;title=Urinary+versus+plasma+neutrophil+gelatinase-associated+lipocalin+(NGAL)+as+a+predictor+of+mortality+for+acute+kidney+injury+in+intensive+care+unit+patients&amp;author=A+Mahmoodpoor&amp;author=H+Hamishehkar&amp;author=V+Fattahi&amp;author=S+Sanaie&amp;author=P+Arora&amp;volume=44&amp;publication_year=2018&amp;pages=12-17&amp;pmid=29100016&amp;doi=10.1016/j.jclinane.2017.10.010&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR42">42. <span class="element-citation">Flannery AH, Bosler K, Ortiz-Soriano VM, Gianella F, Prado V, Lambert J, et al. Kidney biomarkers and major adverse kidney events in critically ill patients. <span><span class="ref-journal">Kidney 360. </span>2021;<span class="ref-vol">2</span>(1):26–32. doi: 10.34067/KID.0003552020.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8785730/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/35368827" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.34067%2FKID.0003552020" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+360.&amp;title=Kidney+biomarkers+and+major+adverse+kidney+events+in+critically+ill+patients&amp;author=AH+Flannery&amp;author=K+Bosler&amp;author=VM+Ortiz-Soriano&amp;author=F+Gianella&amp;author=V+Prado&amp;volume=2&amp;issue=1&amp;publication_year=2021&amp;pages=26-32&amp;pmid=35368827&amp;doi=10.34067/KID.0003552020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR43">43. <span class="element-citation">Asada T, Isshiki R, Hayase N, Sumida M, Inokuchi R, Noiri E, et al. Impact of clinical context on acute kidney injury biomarker performances: differences between neutrophil gelatinase-associated lipocalin and L-type fatty acid-binding protein. <span><span class="ref-journal">Sci Rep. </span>2016;<span class="ref-vol">6</span>:33077. doi: 10.1038/srep33077.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5015077/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27605390" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1038%2Fsrep33077" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Rep&amp;title=Impact+of+clinical+context+on+acute+kidney+injury+biomarker+performances:+differences+between+neutrophil+gelatinase-associated+lipocalin+and+L-type+fatty+acid-binding+protein&amp;author=T+Asada&amp;author=R+Isshiki&amp;author=N+Hayase&amp;author=M+Sumida&amp;author=R+Inokuchi&amp;volume=6&amp;publication_year=2016&amp;pages=33077&amp;pmid=27605390&amp;doi=10.1038/srep33077&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR44">44. <span class="element-citation">Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G. Classifying AKI by urine output versus serum creatinine level. <span><span class="ref-journal">J Am Soc Nephrol. </span>2015;<span class="ref-vol">26</span>(9):2231–2238. doi: 10.1681/ASN.2014070724.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4552117/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25568178" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1681%2FASN.2014070724" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Soc+Nephrol&amp;title=Classifying+AKI+by+urine+output+versus+serum+creatinine+level&amp;author=JA+Kellum&amp;author=FE+Sileanu&amp;author=R+Murugan&amp;author=N+Lucko&amp;author=AD+Shaw&amp;volume=26&amp;issue=9&amp;publication_year=2015&amp;pages=2231-2238&amp;pmid=25568178&amp;doi=10.1681/ASN.2014070724&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR45">45. <span class="element-citation">Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL. Epidemiology of acute kidney injury in critically ill children and young adults. <span><span class="ref-journal">N Engl J Med. </span>2017;<span class="ref-vol">376</span>(1):11–20. doi: 10.1056/NEJMoa1611391.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5322803/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27959707" ref="reftype=pubmed&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1056%2FNEJMoa1611391" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Epidemiology+of+acute+kidney+injury+in+critically+ill+children+and+young+adults&amp;author=A+Kaddourah&amp;author=RK+Basu&amp;author=SM+Bagshaw&amp;author=SL+Goldstein&amp;volume=376&amp;issue=1&amp;publication_year=2017&amp;pages=11-20&amp;pmid=27959707&amp;doi=10.1056/NEJMoa1611391&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=11156822&amp;issue-id=452695&amp;journal-id=1590&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Annals of Intensive Care</span> are provided here courtesy of <strong>Springer-Verlag</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC11156822/pdf/13613_2024_Article_1328.pdf" class="int-view">PDF (887K)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/11156822/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/11156822/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="11156822" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11156822%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="wpoUBZetjE5unujqfv9CcLfdfYORXfOuWrDekK20OmWKkBtq1AB4pC4o9F42OEh6">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11156822%2F&amp;text=Trajectory%20pattern%20of%20serially%20measured%20acute%20kidney%20injury%20biomarkers%20in%20critically%20ill%20patients%3A%20a%20prospective%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC11156822%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11156822/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC11156822/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/38842613/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC11156822/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/38842613/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC11156822/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/11156822/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript" src="/core/mathjax/2.7.9/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC11156822/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
